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Shiga toxin-producing E. coli (STEC) and Salmonella enterica subspecies 
enterica (S. enterica) are two major foodborne pathogens. They cause almost 1.5 million 
of cases of disease each year in the US. Due to their public health impact, development of 
new methods for their detection and identification are top priority. This research focused 
on identifying alternative molecular methods and markers for the identification of STEC 
and Salmonella. 
First, a suspension array was developed to simultaneously identify the seven most 
prevalent STEC (O26, O45, O103, O111, O121, O145, and O157) in the US. The panel 
targeted genes wzx or wzy and Shigatoxin genes. Testing and optimization employed four 
to eleven isolates of each serotype in the panel. STEC fluorescence values were 30 to 
>270 times greater than those of negative controls, demonstrating the method’s 
effectiveness for the molecular serotyping of STEC. 
STEC strains (n=194) of 43 serotypes were examined for clustered regularly 
interspaced short palindromic repeats (CRISPR) arrays to study relatedness among 
serotypes. A subset of strains (n=81) was analyzed for cas and virulence genes to 
determine a possible relationship. CRISPR spacer content correlated well with serotypes, 
although some strains with different serogroup but the same H type shared identical 
arrays (O26:H11, O103:H11, and O111:H11). cas and virulence genes were not 
associated, but strains with greater probability of causing outbreaks and disease showed 
fewer spacers than those less likely to cause them (p<0.05). Therefore, CRISPR array 
content correlated well with STEC serotype, and CRISPR-cas systems were inversely 
related to strain virulence potential. 
Finally, the CRISPR arrays of 221 S. enterica of 53 serotypes were analyzed to 
define their relationship. CRISPR-cas systems of 50 S. enterica serotype Bareilly (S. 
Bareilly) were analyzed to resolve intra-serotype variations. CRISPR arrays correlated 
well with serotypes, although some serotypes displayed more than one type of array (e.g. 
S. Bareilly). Additionally, CRISPR-cas system elements reflected S. Bareilly phylogeny, 
but the array content was not linked to food vehicle or isolate’s geographical origin. In 
conclusion, CRISPR array are useful for designing molecular serotyping assays, but a 
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Chapter 1: LITERATURE REVIEW 
 
Introduction 
Major foodborne pathogens cause approximately 9.4 million illnesses in the 
United States each year, including more than 55,000 hospitalizations and 1,351 deaths 
(1). Shiga toxin-producing E. coli (STEC) and Salmonella are two of the most 
important foodborne pathogens; they were implicated in 15 of the 17 multistate 
outbreaks produced in 2008 (2), and it is estimated that altogether caused almost 1.5 
million of diseases a year (1). 
Some STEC and Salmonella are associated with human diseases more 
frequently than others; therefore, typing foodborne pathogens is fundamental for 
epidemiological studies. The present review focuses on Shiga toxin-producing E. coli 
and Salmonella as foodborne pathogens and novel approaches for their typing. 
 
Shiga toxin-producing Escherichia coli 
Overview 
Most E. coli are normal member of the gastrointestinal flora; however, some 
subgroups are a threat for human health (3). Shiga toxin-producing E. coli (STEC) is 
among the most important causes of foodborne diseases in the United States and in 




and hemolytic uremic syndrome (HUS) are called enterohaemorragic E. coli (EHEC), 
and E. coli O157:H7 is the most known serotype. 
In early years, research focused on E. coli O157:H7 as it was the first STEC 
causing severe disease and outbreaks (6-8), but more than 400 serotypes have been 
involved in human disease (9). In the US, six serogroups –O26, O45, O103, O111, 
O121 and O145— cause 70% of non O157 STEC diseases (10, 11). As a 
consequence, regulatory agencies recognized the importance of other serogroups and 
US agencies required active surveillance of STEC in early 2000’s (12), and new 
regulations increased the awareness of the big six non-O157 STEC serogroups (13).  
STEC main virulence factor is Shiga toxin (Stx), a cytotoxin similar to 
Shigella dysenteriae toxin type 1 (14). STEC harbors two main types of Stx: Shiga 
toxin 1 (Stx1) and Shiga toxin 2 (Stx2), each one with several variants (Stx1a, Stx1c, 
Stx1d, Stx2b, Stx2c, Stx2d, Stx2dact, Stx2e, Stx2f, Stx2g,) (15) which damage the intestinal 
and kidney cells in cases of HC and HUS respectively (16). 
 
STEC detection, isolation and characterization 
 
STEC detection and identification are challenging. Metabolic features make 
E. coli O157:H7 detection easy by growing colonies on sorbitol-McConkey agar. 
However, other STECs lack unique characteristics useful for detection (17). STEC 
isolation and detection takes several steps. First, samples are cultured and colonies are 
biochemically tested (14, 18). Then, other methods measure toxic effects of Stx on 




genes by PCR (20) or hybridize stx genes directly from colonies (21). Finally, isolates 
are serotyped by a modified Kauffman scheme originally created in 1944 (14). 
 
E. coli serotyping 
E. coli serotypes are defined after their O –somatic— and H –flagellar— 
antigens. The somatic O antigen is a component of the outer membrane in gram 
negative bacteria, and 179 groups are defined to date (22). Subunits of two to six 
carbohydrates structure an O unit, and 20 to 30 O units form the lateral 
polysaccharide chain called O antigen (23) that forms part of the lipopolysaccharide 
(LPS), the essential element of the outer membrane. Additionally, there are 53 H 
antigens, proteins that form the flagella (22). 
The O- antigen gene cluster carries genetic information to synthesize the O 
antigen, and it is part of the bacterial chromosome (23). It is generally located 
between two housekeeping genes –gnd and galF –, and the arrangement and number 
of genes in each O group vary depending on the complexity of the polymer (Fig. I.1). 
Proteins encoded by this cluster have diverse functions during the O-antigen synthesis 
process. For example, genes wzx and wzy codify for the O antigen processing proteins 
flippase and polymerase. These two genes have conserved DNA sequences among a 
serotype, but not between serotypes.  Due to the multiple combinations of sugar 
residues, anomeric configurations and posterior linkages with non-sugar residues, the 
O-antigen is considered exceptionally heterogeneous (23, 24). 
Some STEC serogroups are epidemiologically more related to disease. Thus, 




disease (11). STEC serogrouping relies on the use of a large set of antibodies raised in 
rabbits against each of the known E. coli LPS and flagellar antigens. Consequently, 
serotyping is restricted to laboratories that have the antisera. The technique is time 
consuming, and cross reactions among different antisera may occur. Moreover, 
serotyping is not suitable for every strain, resulting in non-typeable strains. These 
limitations drove the development of molecular methods which provide simplified E. 
coli characterization tools (24, 25). 
Several molecular approaches have been developed for STEC serogrouping. 
Many of these assays target unique genes such as wzx (O-antigen flipase) and wzy (O-
antigen polymerase). Several teams designed simplex and multiplex PCR (22, 25-31) 
for the detection of one or several serotypes at the same time. Real time PCR takes 
advantage of probes, improving assay specificity (32-36); however, they allow only a 
few targets at the same time. Microarrays can detect many targets at the same time 
(20, 37-40), but they are not easily customizable and require specialized equipment 




In recent years, suspension arrays emerged as an alternative to traditional, 
planar microarrays. Advantages are they detect several targets in a single reaction –up 
to 100 in the case of the Luminex ® and Bioplex ® platforms—and can use different 
kind of probes –nucleic acids, antibodies, lipids or carbohydrates. Suspension arrays 
provide numeric data, which is more robust than qualitative information. Each data 




superiority over other methodologies. Finally, suspension arrays are flexible allowing 
homemade design and modifications (41-44). 
Suspension arrays have two main components; color codified polystyrene 
beads and a specialized flow cytromety-like device that detects and classifies beads 
(Fig. I.2.) (41). The beads are dyed with two flourochromes mixed in different ratios 
to produce 100 combinations or bead sectors (45). Probes are attached to bead surface 
and then added to the reaction to hybridize the target. The flow cytometry-like device 
analyzes the reaction by identifying bead types (color code), counting beads of each 
type, and measuring and recording the fluorescence emitted by the reporter molecule 
(42, 43, 45). 
Bead-based suspension arrays have identified and detected different targets in 
molecular biology, immunology, clinical sciences, food microbiology, environmental 
monitoring, and many others (42-44, 46, 47). In food microbiology, suspension arrays 
have detected E. coli, Salmonella, C. jejuni and L. monocytogenes. For instance, 
nucleic acid and antibodies probes identified E. coli at 10
3
 cells and 2.5 cells/ml 
respectively, demonstrating the system’s flexibility and sensitivity (45). Also, 
suspension arrays identified Campylobacter spp. and assessed isolate antimicrobial 
resistance with accuracy equivalent to that obtained by sequencing (48). A suspension 
array panel serotyped Salmonella associated with foodborne illness: A first assay 
identified the six most common serogroups in the US and serotype Paratyphi A (46), 




Salmonella enterica subspecies enterica 
Overview 
Salmonella enterica subspecies enterica is a major cause of bacterial 
foodborne diseases in the US with more than 40,000 laboratory confirmed cases each 
year. Latest estimations indicate Salmonella causes almost 1,300,000 cases a year (1). 
Most Salmonella diseases are self-limited, but death rate reaches 0.5% (1, 50). 
Salmonella also has high prevalence in other countries (51) where less common 
Salmonella serotypes are associated to outbreaks; in Africa, its prevalence increased 
in children and HIV positive population (52). 
Salmonella serotypes have a broad range of hosts, producing different 
symptoms depending on the host species (50).  Salmonella can cause persistent 
infections, so hosts can remain as reservoirs for a long time (51). Finally, Salmonella 
antibiotic resistance is increasing, so treatment of invasive cases of infection is more 
difficult and risk of death has increased (50, 51, 53). 
The main reservoirs of Salmonella enterica are food animals (51), and animal 
derived foods have been frequently associated to disease (54). However, outbreaks 
have also involved produce, evidencing that Salmonella can invade and survive in 
different types of foods (55). For example, some of the last outbreaks of Salmonella 
in the US involved pine nuts, ground turkey, fresh papayas, dwarf frogs, alfalfa 
sprouts, cantaloupes, shell eggs, frozen entrees, peanut butter, etc (54, 56). 
Salmonella nomenclature and serotyping 
Salmonella spp. was first described in the second half of the 19
th
 century, but 




classification scheme based on Salmonella antigenic reactions (49). Since then, 
thousands of Salmonella serotypes have been discovered in different hosts, and new 
ones are described every year. Salmonella nomenclature has changed, but thanks to 
molecular methodologies it is possible to understand their phylogeny (50). 
Salmonella enterica is further divided into six subspecies (I, II, IIIa, IIIb, IV, 
VI, and VII), each one with a variable number of serotypes (49, 50). Similar to E. 
coli, Salmonella serotyping is based on the reaction to O (somatic) and H (flagellin) 
antigens; however, Salmonella serotyping is more complicated because they can 
present two flagellin phases (49). There are 46 Salmonella O antigens and 114 H 
antigens, and different combinations have created 2587 serotypes so far (49). 
Salmonella antigenic formula includes subspecies and the O, H1 and H2 antigens. 
Traditionally, serotypes of subspecies I (Salmonella enterica subspecies enterica), are 
named after the place they were first isolated. Traditionally, serotypes’ names are 
used together with the genera name, omitting species and subspecies. For example, 
the name Salmonella Saintpaul designates Salmonella enterica subspecies enterica 
serotype Saintpaul (50). 
Salmonella serotyping is fundamental for outbreak investigation (49). Also, 
some serotypes cause different symptoms depending on the host, and some are more 
frequently associated with diseases and outbreaks (51). For instance, Salmonella 
serotypes Newport, Typhimurium, Enteritidis, Montevideo and Saintpaul are in the 
top 10 serotypes list of CDC and FDA at the same time. Traditional Salmonella 
serotyping can take 5 days or more (49), and it has the same disadvantages of E. coli 




70% of all isolates reported in the United States; the top 100 serotypes account for 
about 98% of all isolates (57). 
 
Molecular serotyping and subtyping of Salmonella spp 
Molecular genotyping of Nontyphoidal Salmonella is used to identify and 
track strains related more frequently to disease and outbreak (51). The technology 
uses specific genomic sequences that differentiate Salmonella serotypes. 
To serotype Salmonella, several sequences are commonly used: O antigen 
gene cluster genes wzx and wzy genes are O antigen specific. Similarly to E. coli, the 
cluster is located between the genes galF and gnd, but it is known as the rfb region 
(23). Salmonella H antigen sequences are located in two flagellin loci in the genome; 
fliC and fljB. The first one is present in every Salmonella strain, and the second one is 
additional present in diphasic Salmonella (58). Both genes have conserved flanks but 
variable central portions, making them ideal for molecular H typing (49). 
To molecular serotype and subtype Salmonella enterica, different approaches 
have been used: Molecular serotyping based on genes coding for O and H antigen 
based on multiplex PCR (59) and suspension arrays (46, 49), PFGE (60) , 
Microarrays, and MLST (61) among others were developed (62). New molecular 
tools for detection and characterization of Salmonella enterica are highly important 






Salmonella enterica subspecies enterica serotype Bareilly 
 
Salmonella enterica subspecies enterica serotype Bareilly (S. Bareilly) was 
first described in 1928 in India and it has been linked not only to gastroenteritis, but 
also to nosocomial infections (63, 64). In the early 1950’s, it was one of the serotypes 
used for Salmonella experimental infection studies; dosages starting at 125,000 cfu 
caused disease in human volunteers (65). Currently, S. Bareilly is one of the 20 most 
prevalent Salmonella serotypes in the US; from 1999 to 2009, confirmed cases rose 
from 171 to 284 (66%), and its ranking escalated from number 23 to 19. However, 
there are not many studies in this serotype. 
S. Bareilly has been isolated from different host (66). It was found in cobras in 
Thailand (67), pasture feed chickens environment (68), diverse animals in India (66, 
69), etc. In Japan, S. Bareilly was the third more frequently isolated serotype from 
sporadic diarrhea from humans and was also frequently found in lying hens (70), and 
it was isolated from raw poultry in Ireland (71). 
In the past years, this serotype has been associated to several outbreaks (70, 
72, 73). Contaminated bean sprouts affected European countries in 2006 and 2010 
adding up to over 500 cases (73, 74), and recently, S. Bareilly was implicated in a 
multistate outbreak associated to raw scraped ground tuna product, causing over 400 
cases in the United States (72). S. Bareilly subtyping strategies were approached in 
past years: a bacteriophage typing was developed two decades ago (75), and ERIC-
PCR was able to differentiate between strains in 2002 (76); however, there are not 




Other studies focused on antimicrobial resistance of S. Bareilly isolated from 
food. In the US, isolates from pasture raised chicken farms showed high levels of 
resistance against Sulfisoxazole and Novobiocin  and intermediate resistance against 
Tetracycline, Neomycin, and Streptomicyn (68). Also, S. Bareilly was the 9
th
 most 
found Salmonella in imported foods (77), and one of five S. Bareilly found (dace fish, 
Vietnam) displayed resistance to Ampicillin, Chloramphenicol, Sulfamethoxazol, 
Tetracyclin, and Trimethoprim/sulfamethoxazole. Conversely, 16 S. Bareilly isolated 
from Indian seafood were susceptible to every antimicrobial tested (78). 
 
The CRISPR-cas system 
Description 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are loci 
described in approximately 40% of bacteria and 90% of archaea (79-81). They 
represent a heritable immune systems against mobile genetic elements (80, 82-85), 
with self-regulatory (86, 87) and self DNA repair (88, 89) functions proposed as well. 
CRISPR was discovered in E. coli K-12 as an arrangement of repetitive 
sequences located downstream to the gene iap; sequences of 29 nucleotides (nt) were 
separated by variable spacers regions of 32 nt (90). Later, similar structures were 
found in other bacteria and archaea (80, 91). The loci also included a leader sequence 





CRISPR-cas system organization 
Although CRISPR-cas systems vary between species (80, 91, 92), they have 
three general components (Fig. I.3): 
 
a) CRISPR array 
 
They are formed by Repeats, originated from endogenous DNA sequences, 
alternated by Spacers, acquired from foreign DNA. Repeats are of almost 
indistinguishable size and sequence in a defined locus (81, 85, 93), and due to their 
palindromic nature, they form stable secondary structures that are fundamental for 
CRISPR function (79). Spacers’ length varies from 20 to 72 bp, but they are unique 
and their length is constant in the same array (80, 81). Array length and number of 
arrays varies between species and strains (80, 87, 94); documented array length goes 
from 2 to 375 repeats (85). 
 
b) Leader sequence 
 
The Leader sequences are 20 to 534 base pair AT rich sequences located 
immediately upstream from the array (80). Their sequence is conserved within the 
same species but not between them (81, 91). Leader sequences lack open reading 
frames, but they carry the promoter for the array transcription (95); therefore, they are 
a crucial component of CRISPR systems, and arrays lacking the leader sequence 






c) Cas proteins 
 
CRISPR associated proteins (Cas proteins) are closely related to CRISPR loci. 
cas genes surround the array, but may be located in different orientation and order 
(81, 96). 
Originally, Cas proteins were classified into 3 families: i) Core cas proteins, 
cas 1 to 6 in different combinations; ii) Eight specific cas proteins subtypes –
CRISPR-Cas subtypes Ecoli, Ypest, Nmeni, Dvulg, Tneap, Hmari, Apern, and 
Mtube— associated with Core cas genes but limited to a narrower group of species; 
and iii) Modular cas genes that can be distant from the CRISPR array (92). Under a 
new classification, genes cas1 and cas2 are universal markers for CRISPR-cas 
systems (85, 97), yet genes codifying for nucleases, helicases, and polymerases may 
be present (85, 96, 98, 99). In E. coli, CRISPR 1’s genes form the I-E CRISPR-cas 
system, and it includes genes cas2, cas1, cas6e, cas5, cas7, cse2, cse1, and cas3 (97). 
Genes cas6e, cas5, cas7, cse2, cse1 form CASCADE –CRISPR associated complex 
for antiviral defense—complex with roles in maturation and interference steps. 
CASCADE transcripts links to one copy of crRNA, and is the basis for recognition 
and neutralization of alien DNA (99). 
 
CRISPR mechanism of action 
CRISPR’s mechanism of action is divided in three stages (82, 83, 100, 101). 
a) CRISPR adaptation:  




i) Sampling: After bacterial systems recognize foreign DNA from phage, 
plasmids or other mobile genetic elements inside the cell (102), short sequences, 
known as protospacers, are removed from the invader (81, 84, 91). 
ii) Integration: CRISPR array inserts a protospacer as new spacer, proximal to 
the Leader sequence (85). 
b) CRISPR expression 
Assembly of the CRISPR functional structure also happens in two steps: 
i) Transcription: Unidirectional transcription of the entire CRISPR, from the 
leader sequence to the terminal spacer, creating a long pre-crRNA. (103, 104). 
ii) Maturation: Small crRNA are cleaved from the long pre-crRNA and linked to 
CASCADE (84). Each crRNA is formed by an entire spacer and short flanking 
regions from the adjacent repeats. The 5’ crRNA side starts with the last 8 nucleotides 
of the 5’flanking repeat (103), and it ends with a non-constant number of nucleotides 
coming from the 3’ flanking repeat (91). Handles are conserved sites for the binding 
of CASCADE (103). 
 
c) CRISPR interference 
crRNA/CASCADE complex inactivates the phage by nucleic acid degradation 
(84). A spacer, homologous to the foreign nucleic acid (82, 101), works as a probe for 
the CRISPR-mediated interference system (82, 103, 105). The complex binds to a 
complementary sequence forming a double stranded DNA molecule, and an R loop is 
formed through Watson and Crick base pairing between crRNA and the protospacer 




direction (98, 106). The R loop works as a marker for the catalytic action of enzymes 
such as cas3 (99). 
Interference depends on the base pairing between the crRNA and the protospacer, 
but the system accepts up to 4 to 5 mismatches before halting (106). 
 
Use of CRISPR for bacterial subtyping 
Spacer acquisition is as a natural process in prokaryotes, and changes in spacers 
would evidence population changes (91, 107). For example, two neighboring 
extremophiles populations had similar CRISPR systems, but their spacer content was 
totally different. Those communities were expected to be clonal (108). CRISPR 
spacers would show the exposures a bacterial lineage survived (81). 
The high variability in spacers could be used for phylogenetic and evolutionary 
studies (91). Spacers should show extraordinary variability because they are a 
byproduct of infections by mobile elements present in the host’s environment, and 
they should evidence geographical locations (85). Even closely related strains should 
display different spacers (81). Moreover, since newer spacers are acquired proximal 
to the leader sequence, CRISPR arrays represent a chronological record of invasions 
(109); therefore, distal location indicates an older origin, and those spacers tend to be 
more frequent among strains (110). However, not all the spacers are kept, and 
sporadic deletions of internal spacers are described (83). 





Kamerbeek and cols. developed a method –Spoligotyping—to detect and 
subtype Mycobacterium tuberculosis for diagnosis and epidemiology. After PCR and 
hybridization, the detection of particular spacers defined the specie and strain present 
(111). The methodology was evaluated later in a clinical setting, helping to select the 
right treatment and shortening diagnosis time in 70 days when compared to culture 
and antibiotic resistance tests (112). 
CRISPR array was used to study the diversity of bacterial Streptococcus spp. 
communities in the oral cavity: The change in spacers in time evidenced an evolution 
of Streptococcus spp. oral flora (113). 
CRISPR was useful for subtyping Campylobacter jejuni. A high resolution 
DNA melt curve analysis of 22 different CRISPR types concluded this methodology, 
used in combination with other real time techniques, provides an equal or superior 
method to PFGE subtyping (114). 
 
CRISPR in Salmonella and E. coli subtyping 
Basic research of the CRISPR-cas system has been carried out in E. coli; 
however, a few studies focused on the CRISPR array diversity of this species or in 
Salmonella enterica. 
 E. coli and Salmonella CRISPR arrays were described as poor 
epidemiological markers because of slow rate of change; strains that diverged in the 
last 250 thousand years had an almost identical CRISPR array (115). Touchon and 
cols. later confirmed that close related strains had identical CRISPR arrays (87). 




(94), and recently, studies demonstrated the relationship between CRISPR array 
content and serotypes. Delannoy et al. reported the presence of specific CRISPR 
polymorphisms related to O:H serotypes of STEC which were useful to differentiate 
these serotypes (116, 117). Similarly, Yin et al. confirmed a relationship between 
CRISPR polymorphism and serotypes (118). 
Salmonella enterica’s CRISPR-cas system would drive Salmonella evolution; 
CRISPR-mediated immunity would prevent strains to evolve in the same way, 
promoting the development of new subtypes and emergence of new S. enterica 
sublineages. Also, CRISPR systems could be controlling the acquisition of plasmid 
and phage mediated horizontal gene transfer (HGT), which has been associated to 
virulence factors in S. enterica. (119).  
 
CRISPR-cas system association with bacterial virulence 
The function of CRISPR-cas systems would be to protect bacteria and archaea 
against foreign genetic elements. Since many virulence determinants are acquired 
through horizontal gene transfer (120), it is possible CRISPR-cas systems interfere 
with the acquisition of virulence determinants. However, it is still controversial 
whether there is a relationship between the acquisition of virulence elements and the 
presence of CRISPR-cas systems. 
Multiples studies evidenced the relationship between CRISPR-cas systems 
and virulence elements in bacteria. Streptococcus thermophillus with longer CRISPR 
arrays were more resilient to alien DNA (82). The presence of CRISPR-cas systems 




evidence of spacer identity with vectors for antibiotic resistance or known mobile 
genetic elements was found (121). An artificially incorporated spacer added to S. 
thermophillus CRISPR1 caused the loss of a plasmid carrying antibiotic (122). In 
Enterococcus spp, an inverse correlation was reported between the presence of two 
virulence genes and the distribution of cas genes, and fewer virulence genes were 
detected when cas genes were present (123). In E. coli, the acquisition of plasmids 
carrying antimicrobial genes was not related to the presence of the CRISPR-cas 
system (124). However, a recent study showed uropathogenic E. coli seemed less 
likely to have CRISPR loci than non-uropathogenic E. coli strains from the same 
patient, suggesting CRISPR-cas may have a role in the acquisition of phage and 
plasmids and serving as an adaptive advantage for the group (125). These findings are 
consistent with the documented role of CRISPR-Cas immune systems in limiting the 
uptake of genetic material derived from mobile and invasive elements such as phages 
and plasmids, yet experiments have failed in proving that wild type E. coli CRISPR 
systems actively function as immune systems (87, 101, 126). 
New evidence indicates the relationship between CRISPR-cas systems and 
bacterial virulence may be indirect. For example, cas9 from Franciscella novocida 
prevents host recognition by indirect gene regulation (127), and Legionella 
pneumophilla’s cas2 is required for intracellular infection of amoebae –an 
amplification step in their lifecycle (128). Non-functional CRISPR are associated to 
more pathogenic Campylobacter jejuni strains; a higher production of gangliosides 
(linked to Guillain-Barré syndrome) would make strains more resistant to phage, 







Serotyping is one of the most extensively used tools to characterize foodborne 
pathogens; information provided is of great use in epidemiological investigations 
(46). Conversely, traditional serotyping methods are restricted to few laboratories due 
to its technical difficulties. In recent years, genomic sequences are broadly available 
which has driven the development of different molecular techniques (36, 39, 40, 46). 
The application of new techniques and the identification of novel markers for 
molecular serogrouping, serotyping, and subtyping are two main lines of research in 
the food microbiology field. The aim of this research was to explore the use of 
different approaches in molecular serotyping of food borne pathogens, and the 
identification of molecular markers. 
 
1. To develop a simultaneous molecular serogrouping methodology for Shiga 
toxin-producing Escherichia coli. 
Molecular techniques identifying STEC serotypes have been previously 
developed, however, most of those assays require several runs to identify whether a 
strains belongs to one of the most common STEC serotypes. Thus, the first objective 
of this research was to develop a suspension array assay that identifies the 7 most 
common STEC isolates in a single reaction. The assay simultaneously indicates the 
presence of shiga toxin. This is the first time all these targets are detected in a single 
reaction assay. These findings were published in the journal Foodborne Pathogens 





2. To describe CRISPR array in shiga toxin-producing Escherichia coli (STEC) 
and determine the association of CRISPR-cas system elements with virulence 
profiles in STEC. 
CRISPR (Clustered regularly interspaced short palindromic repeats) are bacterial 
immune systems protecting the cell against the invasion of foreign elements. CRISPR 
systems are dynamics, and array section would change depending on the environment 
a bacterial lineage evolved. In this study, CRISRP arrays of STEC were analyzed to 
establish the relationships between CRISPR arrays and STEC serotypes. 
Additionally, since many virulence determinants are acquired through horizontal gene 
transfer, the relationship between different CRISPR-cas system elements and some 
virulence markers in STEC was investigated. These findings were recently published 
in the journal Applied and Environmental Microbiology (131) 
3. To describe CRISPR arrays in Salmonella serotypes and study CRISPR-cas 
system in Salmonella Bareilly (S. Bareilly).  
In this study, the relationship between CRISPR array content and Salmonella 
serotypes was analyzed. The use of CRISPR-cas system for subtyping was analyzed 
by studying the variation among strains of S. Bareilly, a non-well studied serotype. 
The relationships between CRISPR-cas system components and strain characteristics 
such as food of isolation, and geographical origin were investigated. Additionally, 
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1.9 Figures and Tables 
 
Figure I.1. O antigen gene cluster organization in E. coli serotypes. 
 
O antigen gene clusters have different genes depending on the serotypes, but many of 
the genes are present in all the serotypes, but in different order. 
Each box represents a gene in the O antigen gene cluster. Orange boxes represent 
housekeeping genes (galF and gnd). Red boxes represent genes wzx and wzy (flippase 










Red triangle represents red laser detecting the bead color/region. Green triangle 
represents green laser detecting the presence of biotin-SA-PE complex quantifying 
the reaction. 
DNA probe is linked to the bead through a C12 attached to its 5’end. 
Reverse primer has a 5’modification (biotin) which allows the inclusion of the 
molecule in the amplicons. 











“The cas genes (cas3, casABCDE, cas1 and cas2) are shown along with the coupled 
CRISPR array. Within the CRISPR array three distinctive elements are found: leader 
sequence (L), repeats (R) and spacers (S). One repeat and one spacer constitute one 
CRISPR unit (shown also as DNA sequence). The region colored light green 
wintergenic region between casA (ygcL) and cas3 (ygcB) (IGLB)x is believed to 
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Chapter 2: Molecular serotyping of Shiga Toxin-producing 
Escherichia coli using suspension array (1) 
 
2.1. Abstract 
Shiga toxin-producing E. coli (STEC) cause serious foodborne diseases. 
Although E. coli O157:H7 has been the dominant STEC serotype, other serotypes 
have been involved in outbreaks and sporadic illnesses worldwide. In this work, a 
suspension array assay was developed to simultaneously serogroup the seven most 
prevalent STEC (O26, O45, O103, O111, O121, O145, and O157) in the US. A 
suspension array panel was designed targeting genes wzx or wzy; probes detecting 
Shiga toxin genes, stx1 and stx2, were included as well. For each serogroup in the 
assay, four to eleven isolates were used for testing and optimization. Fluorescence 
values of 59 STEC were 30 to >270 times greater than the signals of negative 





Shiga toxin-producing Escherichia coli (STEC) are a leading cause of 
foodborne diseases in the US (2-5). Although O157:H7 has been the major STEC 
serotype associated with outbreaks in the US, other important serogroups emerged in 
the past years (6, 7); serogroups O26, O45, O103, O111, O121, and O145 caused 




Additionally, certain non-O157 STEC have been identified as more common than 
O157 in other parts of the world (9). The US Department of Agriculture recently 
extended a zero-tolerance policy for E. coli O157:H7 in raw beef products by 
declaring the six additional STEC serogroups as adulterants (10). Due to their 
potential virulence, timely detection and identification of major non-O157 STEC in 
clinical, food, and environmental samples is important to ensure public health. 
Molecular methods have been developed for serotyping E. coli as an 
alternative for traditional serotyping (11-15). These methodologies target serogroup 
genes (wzx and/or wzy) that encode serogroup specific proteins forming the O antigen 
of Gram-negative bacteria (16).When specific sequences are detected, a serotype is 
attributed to the tested isolate. However, most assays are not suitable for the 
identification of multiple targets in a single reaction (17-19), or for the application to 
a large number of samples (13, 15, 20, 21). In this study, a bead-based suspension 
array (Bio-Plex ™) was explored as an alternative for discriminating among the seven 
STEC serogroups in a single reaction. In this assay, nucleic acid probes are linked to 
beads and hybridized to the target of interest (22), followed by a detection using a 




The present study aimed to develop a suspension array to identify seven STEC 
serogroups – O26, O45, O103, O111, O121, O145, and O157 – which most 




2.4. Materials and Methods 
2.4.1. DNA sequences 
O antigen genes wzx (flipase) and wzy (polymerase) sequences were obtained 
for serotypes O26, O45, O103, O111, O121, O145, and O157 from GenBank data 
base. For a comprehensive detection of STEC, sequences for shiga toxin genes –stx1 
and stx2—were added to the design. Consensus sequences for each one of the targets 
were crafted from several sequences using BioEdit v.5.0.9.  
 
2.4.2. Designing selective primers and probes. 
Specific DNA primer pairs and probes were simultaneously designed using 
the software visual OMP (DNA software Inc., Ann Arbor, MI) for all the targets. 
Parameters included; oligonucleotide length of 25±3 bp, amplicon size of 350±150bp, 
melting temperature (Tm) of 60º C, no mismatches between oligonucleotide and 
target sequence, and no mishybridazation or crosshybridization to the target or 
between oligonucleotides. Probes were designed with an amino C12 modification at 
the 5’end for coupling to the micro beads (Bio-Rad, Hercules, CA) and biotin in the 
reverse primer to allow reaction detection by the lasers. 
Multiplex-PCR reactions and hybridizations were simulated to search for any 
non-specific bindings between primers, probes, and amplified DNA using the visual 
OMP. Then, primers and probes were analyzed through BLAST (Basic Local 




target; any probe hybridizing any unwanted sequences was modified or replaced, 
ensuring it only matched the specific serotype. 
A final hybridization simulation was run with the TMAC buffer option on 
(Tetra Methyl Ammonium Chloride, Sigma Aldrich, St. Luis, MO); TMAC buffer 
eliminates the difference in melting temperature due to different CG ratio, therefore 
only the probe’s length determines its melting temperature. After simulations cleared 
any possible interaction, primers and probes selected were ordered from Biosearch 
technologies (Novato, CA). 
 
2.4.3. Bacterial strains 
A total of 103 bacterial strains were used to evaluate the panel specificity, 
including 59 STEC (4 to 11 isolates for each of the 7 STEC serogroups), 23 of other 
E. coli serogroups, and 21 of non-E. coli species including four Shigella spp., four 
Salmonella serotypes, Proteus vulgaris, Pseudomonas aeruginosa, Enterobacter 
aerogenes, Citrobacter freundii, Hafnia alvei, Enterobacter cloacae, Acinetobacter 
baumannii, three Listeria spp., Streptococcus faecalis, and Bacillus subtilis (Tables 
II.1 and II.2). 
 
2.4.4. DNA isolation and amplification 
 Instagene matrix (Bio-Rad, Hercules, CA) was used for DNA extraction 
following manufacturer instructions (23). Briefly, colonies from an overnight pure 




centrifugation (10,000 rpm for 2 minutes); supernatant was discarded, and 200uL of 
Instagene ™ matrix were added. The mixture was vortexed and incubated for 30 min 
at 56°C followed by an additional incubation step of 8 min at 100°C. Then, the 
sample was centrifuged (10.000 rpm for 2 minutes) and supernatant containing DNA 
was transferred to a new tube. Finally, DNA was standardized at ~100 ng/uL, 
aliquoted, and stored at -20°C until used. 
HotStarTaq Plus Master mix (12.5 uL) (Qiagen, Valencia, CA) was used for 
PCR amplification; 40 nM of forward primers and 160 nM biotinalated reverse 
primers were added to the reaction. Previously extracted DNA was added in a volume 
of 1 uL of DNA, and nuclease free water was used to reach a final reaction volume of 
25 uL. The PCR parameters were as follow: initial denaturation at 95 °C for 5 min; 
followed by 30 cycles of 94 °C for 30 s, 56 °C for 90 s, 72 °C for 90 s; then a final 
elongation at 72 °C for 10 min. 
To verify amplification of the target, amplicons generated by PCR were 
detected by 2% gel electrophoresis. This step was run only during the implementation 
stage. 
 
2.4.5. Probe to bead coupling 
A previously described method was applied for probe to bead coupling (24). 
Briefly, 5 x 10
6 
microbeads were resuspended in distilled water and transferred to a 
copolymer microfuge tube (USA scientific, Ocala, FL). Beads were pelleted by 
centrifugation and then re-suspended in 0.1 M MES buffer. Capture probes were 




beads. 2.5 µl of 10 mg/ml EDC (1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
hydrochloride) (Pierce biotechnology, Thermo scientific, Rockfort, IL) were added to 
each reaction to facilitate the coupling, and then the tube was incubated in the dark 
for 30 min. This step was repeated before adding one ml of 0.02 % Tween-20 to 
beads, followed by centrifugation and washing with 1 ml 0.1 % SDS. Beads were 
resuspended in 100 µl TE buffer, enumerated using BioRad bead counter, 
standardized for concentration, and stored in the dark at 4 °C. 
 
2.4.6. Bead hybridization and detection protocol 
For probe hybridization, coupled beads were diluted 1:100 in 1.5x TMAC 
buffer (1.5 M tetramethylammonium chloride, 75mM Tris, 6 mM EDTA, and 0.15% 
sarkosyl at pH 8.0) to create a bead pool, and 33 µl of the bead mixture were added to 
5 µl of PCR product and 12 µl of TE buffer followed by 5 minute incubation at 94°C 
followed by 15 minute at 55°C. Streptavidin-Phycoerythrin (SA-PE, Invitrogen, 
Carsbad, CA) was diluted to 4 µg/ml in 1x TMAC and 75 µl were added to every 
well; mixture was incubated at hybridization temperature (55 °C) for 10 min. 
Fluorescence detection was performed immediately using Bio-Plex 200 ™ 
(Bio-Rad) at 55° C. A red laser excites the dyes on the surface of the beads and 
allows the identification of the unique bead type; a green laser excites the fluorophore 
(SA-PE) linked to the biotin, allowing to quantify the binding of a specific probe. 
Records for Median Fluorescence Intensity (MFI) from 100 beads per region 
per well, Positive MFI /Negative control MFI ratio (P/N) (25), and bead count were 






Manager software provides an automatic calculation of the P/N ratios as follows: MFI 
from a probe in a sample is divided by the MFI of the same probe in the negative 
control. This methodology was previously described by other authors (25, 26). Data 
were analyzed using ANOVA with SAS program (v9.2). 
 
2.5. Results 
 2.5.1. Primers and probes design 
 After multiple rounds of simulations and laboratory testing, nine probes and 
18 primers were selected for the final suspension array panel (Table II.3). O antigen 
primers and probes were designed de novo; four of them targeted the wzy gene while 
three aimed for wzx. Previously described primers were used for stx1 and stx2 genes 
(27, 28), and new probes were designed based on predicted amplicons. Primers and 
probes ranged in size from 21 to 27 bp, and amplicon size ranged from 180 to 438 bp 
(Table II.3). 
 
 2.5.2. Multiplex PCR 
 From each STEC serogroup, four to eleven isolates were selected and 
amplified successfully with the designed primers. STEC stains showed one, two, or 
three bands depending on the presence of one or two shiga toxin genes. Amplicons 
generated were specific for each primer pair, and the DNA of each target was 





 2.5.3. Suspension Array detection/Molecular serogrouping 
The MFI produced by 100 microspheres of each one of the probes was 
homogeneous among positive samples to a same target, but there were large 
differences between targets. For instance, MFI average value for positive samples to 
probe O26 was 6479 (SD= 471), for probe O45 was12078 (SD=1010), and for probe 
O157 was 18722 (SD=890). Average values for negative samples were 140 (Fig. II. 
2). MFI values of positive samples were significantly greater (p<0.05) than those of 
negative samples in each serogroup (Fig. II.2). 
Similarly , average P/N ratios for positive samples/targets ranged depending 
on the target: 32.8±2.49 for O26 (n=11), 127.6±9.91 for O45 (n=5), 53.0±2.83 for 
O103 (n=5), 144.6±16.91 for O111 (n=5), 207.0±6.53 for O121 (n=4), 153.7±3.89 
for O145 (n=6), 270.9±11.03 for O157 (n=11), 121.5±19.49 for stx1 (n=48), and 
30.7±1.83 for stx2 (n=18). The average P/N ratio for non-specific interactions was 
1.08. Since non-specific interactions never gave P/N values over 13, a cutoff ratio of 
15 was set for serogroup/shigatoxin identification (Table II.4). 
None of the 23 non-STEC E. coli nor 21 non-E. coli strains gave a positive 
reaction (P/N ratio ≥15) for any of the probes tested, except for Shigella dysenteriae, 
which was tested positive for stx1 (Table II.5). 
 
2.6. Discussion 
In the present study, the method developed successfully identified the 7 most 
common STEC serogroups causing human disease in the US. Nine sets of primers 




strains included in the panel. This is the first time a suspension array assay identifies 
not only strain serogroups but also shiga toxin genes, and it represents a reliable 
alternative for molecular serogrouping of E. coli. 
DNA based methodologies have been previously used to serogroup E. coli. 
Multiplex PCR assays detect a limited number of targets due to low band resolution 
of gel electrophoresis (11, 13, 18), and real time PCR are also restricted due to the 
number of channels available for florescence reading. Some real time PCR assays run 
two to three reactions per sample to identify the seven most common STEC in the US 
(15, 21, 29). Conversely, this suspension array interrogates samples simultaneously 
for all nine targets at the same time. Microarrays also identify multiple E. coli 
serotypes at the same time (30, 31), but they are difficult to customize and require 
expensive equipment for reaction preparation and results reading. While suspension 
array also require a specialized detector to read results, any conventional 
thermocycler can perform the amplification step, and no other device is required for 
the analysis. Moreover, panel modifications are done by adding or subtracting 
primers and probes to the system. These advantages make suspension arrays a 
suitable option for STEC serogrouping. 
Genes wzx and wzy were selected as targets. Both genes are located in the O 
antigen gene cluster which carries the information for the O antigen synthesis (16). 
Molecular analysis revealed these genes are conserved among strains of the same 
serogroup while differing between them, and they are broadly used for STEC 
serogrouping (18, 19, 31). In this study, these sequences demonstrated to be specific 




results. Cross reactions in suspension arrays have been also described in other studies 
at similar levels (32). 
Typical P/N ratios obtained in this study were higher than those reported 
elsewhere. Ratios in a Salmonella serogrouping panel ranged from 18 to 155 (26), 
and 8 to 23 in a Campylobacter spp. antimicrobial resistance assay (33). P/N values in 
this study ranged from 30 to 270, and consequently, the P/N ratio threshold was also 
set higher (P/N ≥15) than other studies to reduce false positives by discarding 
nonspecific interactions. Interestingly, P/N ratios varied depending on the 
probe/target combination (Fig.II.2), however, this did not interfere with correct 
serogroup identification. This phenomenon was also described by other authors, and 
it could not be attributed to any specific probe characteristic (26). 
The panel was designed for the detection of almost every Shigatoxin gene 
subtype using two probes. Probe stx1 presented some mismatches with subtype stx1d 
resulting in a reduced fluorescence for this interaction although higher than the 
threshold level. Probe stx2 detects all subtypes but stx2f which sequence considerably 
differs from other stx2 and has not been associated to human disease. Both issues can 
be addressed by the addition of additional primers and probes to the design, however, 
it was decided keeping the assay cost effective and not to add those targets for this 
version. Further studies will aim to design a complementary second panel that 
includes other top 20 O STEC serogroups. 
Since the panel was design to identify O types from pure culture, food matrix 
interaction test were not applicable. Future plans include panel optimization for the 




serotypes, but excluded O157, stx1 and stx2 as targets (Lin et al., 2011). Since shiga 
toxin defines STECs, it was decided that it is fundamental to include them in a STEC 
serogrouping panel. 
The use of high throughput technologies helps in a fast identification of 
targets of interest. In this design, samples are interrogated for nine targets at the same 
time, and it can be run in a 96 well format. Detection step takes less than one hour, so 
over 6 runs could be read per day. Adding new other probes the assay can be 
customized, improving the accuracy and sensitivity of the assay. Finally, once the 
panel is optimized for food samples it could help to an early identification of STEC 
and therefore, helping to prevent human disease. 
 
2.7. Conclusion 
In conclusion, this suspension array design provided a fast, reliable and 
improved alternative for the identification of important STEC serotypes, and can be 
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2.9. Tables and Figures 
 












M: 100 bp molecular weight marker. N: Negative control; O26: 1 to 5; O45: 6 to 10; 
O103: 11 to 15; O111: 16 to 20; O121: 21 to 24; O145: 25 to 29; O157: 30 to 35. 
Stx1: 1, 2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 24, 26, 28, 29, 
30, 31, 32, and 34. Stx2: 5, 7, 15, 16, 17, 21, 23, 24, 25, 26, 27, 30, 31, 32, and 34. 
Gel electrophoresis is not a step necessary for the assay, and it was run only during 





Figure II.2. Positive to Negative (P/N) ratios averaged for studied isolates in one 
representative assay. 
 
Bars represent average P/N ratio for the isolates representing a specific serotype or 
Shiga toxin. Lines represent standard deviation. 
P/N ratio is calculated by dividing the fluorescence value of a probe in the sample 





Table II.1. List of E. coli strains used for designing and optimizing suspension array 
assay. 
 
Strain Serotype stx1 stx2 Strain Serotype stx1 stx2 
        
CVM 9935 O26 + - CVM 9602 O111 + - 
CVM 9939 O26 + - CVM 9610 O111 + - 
CVM 9942 O26 + - CVM 9611 O111 + - 
CVM 9945 O26 + - -1387 O111:H8 + - 
CVM 9953 O26 + - UMD 167 O111:H11 + - 
CVM 9965 O26 + - UMD 168 O111:NM + + 
TW 1200 O26:H2 - - SJ13 O111:NM + + 
UMD 141 O26:H11 + - UMD 164 O111:NM + - 
UMD 142 O26:H11 + - TW 1676 O121 + - 
TW 00971 O26:H11 + - -8023 O121:H19 - + 
SJ3 O26:H11 - + TW 8868 O121:H19 - + 
MI3 O45 + - SJ19 O121:H19 + + 
MI4 O45 + - CVM 9785 O145 + - 
UMD 144 O45:H2 + - CVM 9790 O145 - + 
SJ9 O45:H2 + + CVM 9818 O145 - - 
05-0645 O45:H2 + - TW 7865 O145:H28 - + 
CVM 9260 O103 + - TW 08087 O145: NM + - 
CVM 9380 O103 + - SJ23 O145:NM + + 
CVM 9385 O103 + - CVM 3769 O157 + + 
CVM 9397 O103 + - CVM 3755 O157 + + 
CVM 9398 O103 + - BAA 460 O157 + + 
CVM 9353 O103 + - -43893 O157 + - 
CVM 9354 O103 + - TW 14359 O157 - + 
TW 7920 O103:H2 + - FDA 413 O157 - + 
-4162 O103:H6 + - CVM3764 O157 + + 
SJ12 O103:H11 + - EDL 933 O157:H7 + + 
TW 7990 O103:NM + - -85170 O157:H7 - - 
CVM 9591 O111 + - UMD46 O157:H7 + + 
CVM 9592 O111 + - 84-1097 O157:H25 - - 
CVM 9596 O111 + - 
    







Table II.2. List of strains used for exclusivity test for the suspension array. 
 
E. coli  Non E. coli strains 
E. coli K12 Shigella flexnieri ATCC12022 
E. coli O1 Shigella dysenteriae CVM 
E. coli O2 Shigella bordii CVM 
E. coli O5 Shigella sonnei ATCC25931 
E. coli O6 Salmonella Typhimurium LT-2 
E. coli O8 Salmonella Typhimurium ATCC14028 
E. coli O15 Salmonella Enterica ATCC13076 
E. coli O18A Salmonella Enteritidis 
E. coli O22 Proteus vulgaris ATCC13315 
E. coli O28 Psudomonas aeruginosa ATCC27853 
E. coli O55 Enterobacter aerogenes ATCC13048 
E. coli O88 Citrobacter freundii ATCC8090 
E. coli O91 Hafnia alvei UMD375 
E. coli O104 Enterobacter cloacae UMD190 
E. coli O113 Acinetobacter baumanii ATCC19606 
E. coli O118 Listeria monocytogenes ATCC13932 
E. coli O128 Listeria innocua ATCC33090 
E. coli O128ac Listeria grayii ATCC19120 
E. coli O142 Staphylococcus aureus ATCC29213 
E. coli O146 Streptococcus faecalis ATCC19433 
E. coli O153 Bacillus subtilus BIOREM 1-1 
E. coli O174  






Table II.3. Primer and probe sequences, gene target and amplicon size for different E. 
coli serogroups and for Shiga toxins genes (stx1 and stx2) in the Suspension Array 
panel. 
Serogroup Oligo Sequence Gene Product (bp) 
     
 FWD GTGTGTCTGGTTCGTATTTTTTATCTG   
O26 REV CCTTATATCCCAATATAGTACCCACCC wzx 438 
 PROBE AATAAAGCTAAAATTCAATGGGCGGAA   
     
 FWD GGTCGATAACTGGTATGCAATATG   
O45 REV CTAGGCAGAAAGCTATCAACCAC wzx 341 
 PROBE CAACAGTTCTTGCAGACATGATC   
     
 FWD TTATACAAATGGCGTGGATTGGAG   
O103 REV TGCAGACACATGAAAAGTTGATGC wzy 385 
 PROBE GAGCAGTTACGTCAATTACTGGCATG   
     
 FWD CTTCGATGTTGCGAGGAATAATTC   
O111 REV GTGAGACGCCACCAGTTAATTGAAG wzx 362 
 PROBE CAAGAGTGCTCTGGGCTTCTATAGT   
     
 FWD AGTGGGGAAGGGCGTTACTTATC   
O121 REV CAATGAGTGCAGGCAAAATGGAG wzy 366 
 PROBE CCGATATTCTAGTAGCCGTTATTTCAG   
     
 FWD CCTGTCTGTTGCTTCAGCCCTTT   
O145 REV CTGTGCGCGAACCACTGCTAAT wzy 392 
 PROBE TTCATATTGGGCTGCCACTGATG   
     
 FWD TCGTTCTGAATTGGTGTTGCTCA   
O157 REV CTGGTGTCGGAAAGAAATCGTTC wzy 278 
 PROBE GACAAGACGGAGAACAAAATGACTCAT   
     
 FWD ATAAATCGCCATTCGTTGACTAC
a
    
stx1 REV AGAACGCCCACTGAGATCATC
a
 stx1 180 
 PROBE GCATAGTGGAACCTCACTGAC   
     
 FWD GACCATCTTCGTCTGATTATTGAGC   
stx2 REV GCGTCATCGTATACACAGGAGC
b
  stx2 385 
 PROBE GGCGTTAATGGAGTTCAGTGG   
     
a
stx1 FWD and REV described by Paton and Paton (1998). 
b
stx2 REV described by Cebula et al. (1995). 
c
Primers and probes were purchased from Biosearch Technologies. 






Table II.4. Serogroup, Shiga toxin profile, and positive/negative (P/N) ratios for E. coli strains used for developing STEC 
serogrouping panel. 
 
 Strain Profile P/N Ratios 
Strain 
Serotype/ 
Serogroup stx1 stx2 O26 O45 O103 O111 O121 O145 O157 stx1 stx2 
CVM 
9935 
O26 + - 32.62 1.02 0.87 1.24 0.9 0.8 1.72 132.22 0.86 
CVM 
9939 
O26 + - 35.76 0.95 0.84 0.97 0.93 0.71 0.54 144.11 0.61 
CVM 
9942 
O26 + - 31.75 0.87 0.93 0.83 1.1 0.68 0.68 137.04 0.65 
CVM 
9945 
O26 + - 29.54 1.16 1.06 0.94 1.05 0.75 1.14 134.57 0.8 
CVM 
9953 
O26 + - 35.6 0.56 0.89 1.18 0.9 0.72 0.88 151.86 0.59 
CVM 
9965 
O26 + - 34.41 0.88 0.85 0.81 0.73 0.71 0.9 136.96 0.61 
TW 
1200 
O26:H2 - - 36.8 13 0.96 1.28 1.4 0.62 1.29 3.94 0.94 
UMD 
141 
O26:H11 + - 29.95 0.82 0.82 1.13 1.12 0.88 0.93 117.57 0.61 
UMD 
142 
O26:H11 + - 30.31 1.19 0.84 0.98 1 0.9 1.33 121.92 0.7 
TW 
00971 
O26:H11 + - 32.02 0.81 0.85 0.99 0.94 0.84 1.08 120.85 0.6 
SJ3 O26:H11 - + 32.56 1.42 0.87 1.02 0.85 0.63 1.19 3.33 28.63 
MI3 O45 + - 0.76 134.9
1 
0.91 1.16 0.97 1.05 1.64 134.62 0.65 
MI4 O45 + - 0.8 129.8
5 
0.79 1.35 0.84 0.69 0.99 127.75 0.6 
UMD 
144 
O45:H2 + - 0.71 136.5 0.89 1.22 1.04 0.89 1.19 138.35 0.56 
SJ9 O45:H2 + + 0.71 111.8
3 
2.3 0.78 0.84 0.68 1.1 107.85 26.72 
05-0645 O45:H2 + - 0.7 124.9
5 
0.83 0.99 0.93 0.83 1.18 125.14 0.57 
CVM 
9260 
O103 + - 0.73 0.72 52.57 0.93 0.58 0.58 0.87 98.05 0.69 
CVM 
9353 
O103 + - 0.82 1 46.45 1.15 0.97 0.87 0.98 94.63 0.84 
CVM 
9354 
O103 + - 0.77 0.68 53.67 0.87 0.86 0.77 0.91 108.65 0.73 
CVM 
9380 
O103 + - 0.8 0.9 57.92 0.94 0.78 0.95 1.05 117.52 0.62 
CVM 
9385 
O103 + - 0.84 0.77 54.35 0.8 0.87 0.9 1.17 111.17 0.7 
CVM 
9397 
O103 + - 0.87 0.97 54.7 1.05 1.02 1 0.65 94.08 0.73 
CVM 
9398 
O103 + - 0.87 0.92 55.66 1.09 0.98 0.75 0.96 108.65 0.7 
TW 
7920 
O103:H2 + - 0.77 0.95 49.38 0.82 1.28 0.93 1.09 102.45 0.71 




Cont. Strain Profile P/N Ratios 
Strain 
Serotype/ 
Serogroup stx1 stx2 O26 O45 O103 O111 O121 O145 O157 stx1 stx2 
SJ12 O103:H11 + - 0.75 0.98 51.76 1.08 0.95 0.95 0.91 109.96 0.61 
TW 
7990 
O103:NM + - 0.75 0.75 49.81 1.09 0.76 0.75 0.78 100.21 0.64 
CVM 
9591 
O111 + - 0.51 1.13 0.49 165.6
5 
0.92 0.53 1.09 141.59 0.62 
CVM 
9592 
O111 + - 0.58 1.2 0.67 151.2
5 
1.15 0.69 1.54 136.5 0.7 
CVM 
9596 
O111 + - 0.66 1.05 0.5 117.5
4 
1.11 0.83 0.9 112.16 0.69 
CVM 
9602 
O111 + - 0.46 0.9 0.4 157.6
7 
0.86 0.71 0.76 141.15 0.56 
CVM 
9610 
O111 + - 0.53 1.08 0.44 140.0
6 
1.49 0.68 0.84 138.91 0.87 
CVM 
9611 
O111 + - 0.43 0.78 0.36 166.2
1 
0.92 0.66 1.23 143.53 0.59 
-1387 O111:H8 + - 0.44 1.06 0.67 154.1
3 
6.94 1.57 1.38 130.65 1 
UMD 
167 
O111:H11 + - 0.53 0.81 1.6 139.9
2 
4.06 1.07 1.5 127.74 1.27 
UMD 
168 
O111:NM + + 0.62 1.09 0.52 125.8
5 
1.07 0.9 1.3 124.29 29.23 
SJ13 O111:NM + + 0.4 0.84 0.4 122.4
6 
1.14 0.62 0.7 120.48 28.04 
UMD 
164 
O111:NM + - 0.52 0.91 0.6 149.7
2 
2.33 0.78 0.99 128.58 0.62 
TW 
1676 
O121 +* - 0.82 1.31 1.27 0.89 216.0
5 
2.31 2.01 36.42* 0.61 
-8023 O121:H19 - + 0.94 0.94 0.98 1.08 206.5
3 
0.75 0.85 1.59 29.17 
TW 
8868 
O121:H19 - + 1.04 0.91 0.94 0.91 204.8
9 
0.96 1.58 1.06 31.05 
SJ19 O121:H19 + + 0.83 0.79 0.79 0.92 200.5
6 
0.78 1.07 121.56 30.94 
CVM 
9818 
O145 - - 0.89 0.91 0.84 0.97 1.42 150.65 0.95 0.88 0.9 
CVM 
9785 
O145 + - 0.75 1.08 1.72 0.7 11.12 156.38 3.82 118.84 3.71 
CVM 
9790 
O145 - + 0.93 0.89 0.97 0.91 2.67 160.19 1.41 1.3 30.59 
TW 
7865 
O145:H28 - + 0.95 1.05 1.32 1.21 6.03 149.85 1.65 3.42 34.79 
TW 
08087 
O145: NM + - 0.73 0.94 2.02 0.66 5.21 152.94 8.41 129.11 1.53 
SJ23 O145:NM + + 0.73 0.73 0.85 0.92 2.09 152.42 0.81 119.81 30.38 
CVM 
3769 
O157 + + 0.77 0.63 0.85 1.09 0.73 0.64 291.25 134.48 31.85 
CVM 
3755 
O157 + + 0.79 0.65 0.78 0.89 0.72 0.71 279.95 129.04 31.74 
CVM37
64 
O157 + + 0.83 0.71 0.79 1.08 1.33 0.82 270.72 117.61 31.12 
BAA 
460 
O157 + + 0.84 0.69 0.89 0.96 1.29 0.55 257.58 129.3 32.98 
-43893 O157 + - 0.85 0.65 1.02 0.75 0.78 0.71 261.95 143.95 0.74 




Cont. Strain Profile P/N Ratios 
Strain 
Serotype/ 
Serogroup stx1 stx2 O26 O45 O103 O111 O121 O145 O157 stx1 stx2 
TW 
14359 
O157 - + 1.01 0.77 0.94 0.98 0.74 0.66 260.87 0.99 31.43 
FDA 
413 
O157 - + 0.92 0.69 1.05 0.9 0.93 0.53 271.3 1.13 31.28 
EDL 
933 
O157:H7 + + 0.85 0.54 1.01 0.88 0.94 0.89 287.09 135.21 31.23 
-85170 O157:H7 - - 1.02 0.75 0.96 0.94 1.5 0.85 270.38 1.34 1.19 
UMD46 O157:H7 + + 0.82 0.51 0.97 0.98 0.88 0.71 261.9 104.43 31.7 
84-1097 O157:H25 - - 0.95 2.63 1.34 0.99 2.69 1 266.64 2.13 1.21 




Table II.5. Inclusivity and exclusivity test results for the Escherichia coli O antigen 
Suspension Array panel. 
 
Target O26 O45 O103 O111 O121 O145 O157 
E. coli Target serogroups* 11/11 5/5 11/11 11/11 4/4 6/6 11/11 
        
Other E. coli serogroups** 0/23 0/23 0/23 0/23 0/23 0/23 0/23 
        
Other bacterial species*** 0/21 0/21 0/21 0/21 0/21 0/21 0/21 
        
*E. coli O26, O45, O103, O111, O121, O145, and O157. 
**E. coli  K12, O1, O2, O5, O6, O8, O15, O18, O22, O28, O55, O88, O91, O104, 
O113, O118, O128, O128ac, O142, O146, O153, and O174. 
***Shigella flexnieri, S. dysenteriae, S. boydii, S. sonnei, Salmonella Typhimurim 
strain LT2, S. Typhimurium ATCC14028, S. Enteritidis (2 strains), Proteus vulgaris, 
Pseudomonas aeruginosa, Enterobacter aerogenes, Citrobacter freundii, Hafnia 
alvei, Enterobacter cloacae, Acinetobacter calcoaceticus, Listeria monocytogenes, L. 





Chapter 3: Characterization of CRISPR (Cluster Regularly 
Inter-spaced Short Palindromic Repeats) loci in Shiga toxin-
producing Escherichia coli 
 
3.1 Abstract 
Shiga toxin-producing Escherichia coli (STEC) (n=194) representing 43 
serotypes were examined for clustered regularly interspaced short palindromic repeats 
(CRISPR) arrays to study genetic relatedness among STEC serotypes. A subset of the 
strains (n=81) was further analyzed for I-E subtype cas and virulence genes to 
determine possible association of CRISPR elements with virulence. Four types of 
CRISPR arrays were identified. CRISPR1 and CRISPR2 were present in all strains 
tested. One strain also had both CRISPR3 and CRISPR4, whereas 193 strains 
displayed a short, combined array CRISPR3-4. A total of 3,353 spacers were 
identified, representing 528 distinct spacers. The average length of a spacer was 32 
bp. Approximately half of the spacers (54%) were unique, and found in strains of less 
common serotypes. Overall, CRISPR spacer content correlated well with STEC 
serotypes, and identical arrays were shared between strains with different O types but 
the same H type (O26:H11, O103:H11, and O111:H11). There was no association 
between the presence of I-E subtype cas and virulence genes, but the total number of 
spacers correlated negatively with potential pathogenicity significantly (p<0.05). 
Fewer spacers were found in strains that had greater probability of causing outbreaks 
and disease than in those that less likely cause illness (p<0.05). These findings 




CRISPR systems were inversely related to the presence of virulence determinants, 
although this relationship needs to be determined on a broader scale and a biologic 
link will need to be established. 
3.2. Introduction 
Shiga toxin-producing Escherichia coli (STEC) has been recognized as a 
human pathogen since the early 1980’s, when two consecutive outbreaks of STEC 
serotype O157:H7 in contaminated beef patties sickened 47 people in the US (1). To 
date, over 400 additional serotypes have been associated to bacterial gastroenteritis 
worldwide (2) and there are estimated over 175,000 cases of STEC infections each 
year in the US alone (3). Depending on the ability to cause outbreaks and/or severe 
disease, Karmali et al. classified STEC serotypes into seropathotypes (SPT) A to E: 
SPT A causes outbreaks and disease at high rates and SPT E has not been linked to 
outbreaks or severe disease (4). 
Clustered regularly interspaced short palindromic repeats (CRISPR) were first 
discovered in E. coli in 1987 (5) and have now been found in  45  of bacteria and   
90% of archaea (6-8). CRISPRs function as heritable and adaptive immune systems 
against mobile genetic elements (phages, plasmids, etc) (9-11), and are made of three 
components: a leader sequence that carries a promoter for transcription; CRISPR 
associated genes (cas) encoding proteins with multiple functions; and CRISPR arrays 
formed by repeats and spacers (12). While most repeats are typically 
indistinguishable in size and sequence within a defined locus, they are intercalated by 
non-repeated short sequences called spacers, which are of a constant number of 




mobile and invasive genetic elements incorporated into the array and subsequently 
serve as the sequence-specific recognition portion of the immune system (14-16). 
Four CRISPR loci and two CRISPR types are described in E. coli (17-19): 
CRISPR1 is located between iap and cysH, and CRISPR2 is in the region between 
ygcF and ygcE (17, 19). They have identical consensus repeats (20). CRISPR1 
associated proteins form the I-E type system. CRISPR3 and CRISPR4 also have 
identical consensus repeats, and are located between clpA and infA. CRISPR3 cas 
genes form CRISPR type I-F (17, 19, 20). Array size and content vary among 
CRISPR types and strains. It is not common that the four loci are present in a single 
E. coli isolate. CRISPR1 and CRISPR2 are most frequently found in E. coli (19, 21). 
CRISPR arrays evolve by polarized acquisition of novel spacers and represent a 
chronological record of infectious assault on the bacterium from viral and other 
genetic elements. Distal spacers from the leader sequence are older and are common 
among strains, while newer spacers are closer to the leader and more strain specific. 
Occasionally, sporadic deletions of internal spacers do occur (22). Differences in 
spacer content would indicate variations in the host environment and geographical 
locations and may be useful in evolutionary and epidemiological studies (12). This 
variability makes CRISPR arrays suitable genetic markers for bacterial subtyping. 
The primary biological role of CRISPR-Cas systems is to provide acquired 
immunity to protect the cell against mobile genetic elements such as viruses and 
plasmids (10, 11). Conversely, evolution of pathogenic strains is attributed to the 
acquisition of elements through lateral gene transfer, such as transposons, phages, 




serogroups O26, O103, O111, and O157 revealed they have much larger genomes 
than non-pathogenic E. coli, mainly due to a large content of prophages and other 
integrative elements (25). It is expected that strains containing functional CRISPR 
systems restrict the acquisition of mobile genetic elements, and that strains with the 
most complex and active CRISPR systems would have a lower susceptibility to 
infections by mobile genetic elements (19). However, studies on the relationship of 
CRISPR systems and the acquisition of genetic mobile elements resulted in different 
findings. While an inverse relationship was reported between the presence of cas and 
virulence factors in Enterococcus spp., no correlation was found between CRISPR 
and the presence of plasmids containing antimicrobial resistance genes in E. coli (26, 
27). The hypothesis in this study was that CRISPR arrays are a suitable marker for 
STEC serotyping, and that there is an inverse relationship between the presence of 
CRISPR elements and virulence determinants in STEC. 
 
3.3. Objective 
Studies of the CRISPR loci in a variety of STEC are limited. The aim of this 
study was to describe CRISPR arrays of 194 STEC strains of 43 serotypes, to 
investigate the relationship between arrays in important serotypes and to explore 





3.4. Materials and Methods 
3.4.1. Strain collection 
A set of 190 STEC from the food safety laboratory collection at University of 
Maryland strains collection were analyzed, including 30 O26, 30 O103, 41 O111, 6 
O45, 4 O121, 6 O145, 12 O157, and a variable number of strains of other serogroups 
(Table III.1). The strains were isolated from a variety of geographical location and 
sources, including humans, cattle and beef products, sheep, goat, deer, okapi, goat, 
and produce. Collection dates range from 1976 up through 2010. 
 
3.4.2. DNA isolation 
Genomic DNA was extracted from a pure culture after streaking on LB agar 
and incubating at 35º C for 24 h, using Instagene matrix (Bio-Rad, Hercules, CA). 
Briefly, 1-2 colonies were suspended in 1 mL of ultrapure water and centrifuged. 
Supernatant was discarded and 200 uL of Instagene matrix was added followed by 
incubation at 56°C for 15 min and at 94°C for 8 min. After centrifugation, the 
supernatant containing DNA was stored at -20°C until use. 
 
3.4.3. PCR and DNA sequencing 
CRISPR array sequences were obtained through PCR and Sanger sequencing 
using previously described primers (21). PCR reactions consisted of 1 uL of bacterial 
DNA mixed with HotStarTaq Plus Master mix (12.5 µl) (Qiagen, Valencia, CA), 10 




µl. PCR parameters included: initial denaturation at 95 °C for 5 min, 10 cycles of 94 
°C for 30 s, 56 °C for 30 s, 72 °C for 90 s for 10 cycles followed by 25 cycles of 94 
°C for 30 s, 56 °C for 30 s, 72 °C for 90 s plus a 10-s cycle elongation for each 
successive cycle (21). PCR products were sequenced by MCLAB (South San 
Francisco, CA) from both ends using Applied Biosystems ® fluorescent dye 
terminator technology in an ABI 3730xl sequencer with the same PCR primers. 
 
3.4.4. CRISPR array sequence analysis 
Sequences were assembled with the Geneious software v. 6.0.5 (New 
Zealand). Arrays were extracted using the “clean sequence tool” enclosed in a macro 
script/database provided by DuPont, as previously described (28). The tool detected 
repeats listed in a repeat database and automatically separated repeats and the 
intercalated short sequences –spacers— into different columns Data were 
subsequently formatted to a graphic representation of each spacer and repeat based on 
their sequence (28). To corroborate array sequence, each sequence was tested using 
the CRISPRfinder (http://crispr.u-psud.fr/Server/) program online (29). In addition, 
CRISPR sequences of four major STEC serogroups (O26, O103, O111, O157) and E. 
coli K12 were obtained from NCBI and included in the analysis (Table III.1). 
To analyze arrays, strains were arranged based on the presence of common 
consecutive spacers from the distal end to the leader sequence. Strains with the 
longest series of spacers on their array were designated as “anchors”, which were 





3.4.5. Protospacers analysis 
Spacer identity was determined using a standalone blast program (blast+ 
2.2.27) against the NCBI non redundant (nr) nucleotide collection. Protospacers were 
defined as homologous sequences with an e value <1.10e-5 and less than 10% 
difference in sequence length (21). Self matches to E. coli CRISPR loci sequences 
were omitted. 
3.4.6. Nucleotide sequence accession number  
Sequences identified were submitted to GenBank with accession numbers from 
KF522692 to KF523262. 
 
3.4.7. I-E subtype cas screening  
A seropathotype (4) balanced subset of 81 strains were selected based on a 
previous study (30) to screen for the presence of cas1 and cas2, which are markers of 
the I-E system (Table III.1). Primers cas1FW (5’ –CGCCTGCATTATGCTCGAAC- 
3’), cas1REV (5’-CATTTTGCGCACCACCTTCA- 3’), cas2FW (5’-
ATGAGCATGGTCGTGGTTGT- 3’), and cas2REV (5’ –
CCCATCCAAATCCACCGGAA- 3’) were designed based on whole genome 
sequencing (WGS) of 24 strains using Geneoius v. 6.0.5. In separate reactions for I-E 
subtype cas1 and cas2, 12.5 µl of HotStarTaq Plus Master mix (Qiagen) were mixed 
with 10 pM of forward and reverse primers (Invitrogen, Carlsbad, CA), 1 µl of 




initial denaturation at 95 °C for 5 min, 30 cycles of 94 °C for 30 s, 55 °C for 30 s, and 
72 °C for 90 s and a final extension at 72 °C for 10 min. 
 
3.4.8. I-E subtype cas analysis. 
A maximum likelihood phylogenetic tree was constructed based on the 
concatenated sequence of system I-E subtype cas genes (cas1, cas2, cas3’, cse1, cse2, 
cas6e, cas7, cas5) (20) of 16 STEC strains previously sequenced (31) and eight 
publically available E. coli sequences (GenBank)(Table III.1). The tree was 
constructed using Mega 5.1(32) with 1,000 bootstrap iterations, and E. coli K12 was 
used as outgroup. Pairwise distance matrix was calculated based on total 1,014 SNPs 
to display the evolutionary divergence between different groups on the phylogenetic 
tree (Mega 5.1 with 1,000 bootstrap replications).  
 
3.4.9. Virulence genes screening  
The presence of selected virulence genes, stx1, stx2, eae, hlyA, pagC, sen, 
nleB, efa-1, efa-2, terC, ureC, iha, aidA-1, nle2-3, nleG6-2, nleG5-2 ,irp2 and fyuA, 
was obtained for a subset (Table III.1) of strains from a previous study (30). 
3.4.10. Statistical Analysis  
Data were analyzed with SSPS v20. ANOVA or Kruskal-Wallis test was 






In the current work, CRISPR arrays of 194 STEC strains of 43 representative 
serotypes were screened and characterized, and also potential association between 
CRISPRs and virulence genes were evaluated. 
 
3.5.1. CRISPR array 
Four types of CRISPR arrays were identified among the 194 STEC strains and 
E. coli K-12. CRISPR1 and CRISPR2 were present in all 195 strains tested. One 
strain (95-3322) also had CRISPR3 and CRISPR4, whereas 193 strains displayed a 
short, combined array CRISPR3-4 (Table III.2). The length of CRISPR1 and 
CRISPR2 arrays varied from 1 to 20 spacers, with most having 5 or 7 spacers. The 
unique CRISPR3 and CRISPR4 arrays of strain 95-3322 were of 11 and 6 spacers in 
length, respectively, whereas the combined array CRISPR3-4 typically had only one 
spacer (Table III.2). Nearly 90% STEC (173/195) carried an additional array in the I-
E system located at 0.5 kb from CRISPR2 (19). This array (CRISPR2b) had one 
spacer and its sequence was conserved among strains (Data not shown). 
CRISPR1 was less polymorphic than CRISPR2. Most CRISPR1 arrays (94%; 
184/195) shared an ancestral (first) spacer, and many strains (64%; 125/195) also 
shared the second oldest spacer (Fig. III.1), indicating a common origin. However, 
CRISPR2 did not share the first spacer and many shared only the second spacer. Both 
arrays had numerous deletions of spacers, mostly at 2 or 3 spacers. Interestingly, 
despite the observation that the older spacer of CRISPR1 was shared by 184 strains, 




combined arrays, CRISPR3-4 had only one spacer (95%; 180/195), and this same 




3.5.2. Spacer diversity 
A total of 3,353 spacers were identified, from which 528 were distinct. The 
average length of a spacer was 32 bp, ranging from 30 to 35 bp. Approximately half 
of the 528 spacers (54%) were unique (Table III.2) and found in strains of less 
common serotypes (Fig. III.1). Many strains shared spacers in the same CRISPR loci, 
but no spacers were shared between CRISPR loci (Fig. III.1). 
Ten of the 528 spacers had identity with plasmids from Salmonella Enteritidis 
or E. coli (i.e., protospacers). These spacers occurred in 13 strains. Additionally, one 
spacer showed identity to Enterobacteria phage P7 and was present in 12 of the 13 
strains (Table III.3). Most spacers (8/10) with known protospacers formed part of 
CRISPR1, and some strains (7/13) had more than one of these spacers in their array 
(Table III.4). For example, strains XDN 4854 and XDN 5545 contained five and four 
of these spacers in CRISPR1, respectively. CRISPR3 and CRISPR4, found only in 
strain 95-3322, carried one spacer with known protospacers, and it also carried one of 
the spacers in CRISPR1. Locations of these spacers in the array were random, from 
position 1 to position 19. Most strains harboring these spacers were of uncommon 




homologies to phage and plasmids sequences are consistent with a role that CRISPR 
play in resisting mobile genetic elements as previously described in literature (9, 10). 
 
3.5.3. Array organization by serotype 
CRISPR arrays were organized based on the spacer content of anchor strains 
which are defined as those that contain all spacers for a group/cluster in correct order 
representing ancestral strains. Although a universal anchor was not identified, four 
clusters were established, each one with one anchor (Fig. III.1). The first cluster was 
formed by O145 strains, and anchored by a human isolate, 07865, (O145:H28). The 
second group was anchored by CVM 9591 (O111:H11) isolated from cow in 1995. 
The cluster included two subgroups: O111: H8 and O111: NM in a block, and 
O26:H11, O103:H11, and O111:H11, among others, in a second group. The third 
cluster was more diverse, formed by several serotypes including O45:H2, O103:H2, 
O103:H25, O91:H21, and O91:H14. This group was anchored by CVM 9340 
(O103:H25) from human. Last group was also very diverse, anchored by 08023 
(O121:H19). Strains of less common serotypes did not forme clusters. Since 
CRISPR1 and CRISPR2 co-clustered, the same arrangement was achieved using 
either one as a guide (Fig. III.1). This was consistent with a parallel evolution of the 
two CRISPR loci over time.  
Strain clustering based on CRISPR spacer content correlated well with STEC 
serotype status. For instance, serotype O111:H8 formed a large cluster of 29 strains 
that had almost identical spacer contents with only a few minor deletions of 1 or 2 




O26:H11, O103:H2 and O157:H7. Unique, long CRISPR arrays were present in less 
common STEC serotypes (Fig. III.1). These data underscore the notion that CRISPR 
elements may serve as reliable discriminatory signatures at least down to the level of 
serotype for STEC strain lineages. 
It was notable that spacer content seemed to correlate well with strains 
retaining the same H antigen type, but not necessarily with strains having the same O 
group. For example, O103:H2 did not share any spacer in CRISPR2 with O103:H11, 
although they did have common ancestral spacers in CRISPR1 (3/12). However, 
O103:H2 clustered together with O45:H2, and contained identical spaces in CRISPR1 
up to the fourth spacer where O103:H2 had additional eight spacers. Similarly, 
O45:H2 and O103:H2 differed only by one spacer deletion in CRISPR2 (Fig. III.2). 
On the other hand, only nine of 17 spacers were shared by strains between O111:H8 
and O111:H11, whereas strains of O26:H11 and O103:H11had practically identical 
arrays, forming a sub-cluster based on antigen H11 (Fig III.1). Taken together, these 
data may point to H antigen loci as more phylogenetic stable while O antigen alleles 
appear to be shuffled in the evolution of STEC clades (31). 
 
3.5.4. Correlation between CRISPR content and occurrence of virulence genes 
Previous reports indicate an inverse correlation between the presence of 
virulence genes and the distribution of cas genes in Enterococcus fecalis (E. fecalis) 
(27). Therefore, a subset of strains (n=81) of different STEC seropathotypes (Table 
III.1) was analyzed for virulence genes (30) and the presence of I-E subtype cas 




such high positive rates, there was no significant difference in the presence of I-E 
subtype cas among different seropathotypes. Similarly, no association between the 
presence of I-E subtype cas and virulence genes was observed. 
A significant difference was observed in the total content of spacers between 
strains of different seropathotypes (p<0.05) (Fig III.2a), and fewer spacers were found 
in strains that had greater probability of causing outbreaks (SPT A and B) compared 
to those with lower probability (p<0.05) (Fig. III.2b). Similarly, strains with higher 
potential of causing severe disease (SPT A, B and C) had fewer spacers than those 
with lower potential (SPT D and E) (p<0.05) (Fig. III.2c). An association between the 
number of spacers and the presence of certain virulence genes was also observed. For 
example, eae-positive strains had significantly fewer spacers than eae-negative strains 
(p<0.05). Other virulence genes including pagC, sen, terC, ureC, nleB, nle2-3, nleG6-
2, and nleG5-2 also showed the same significant relationship with the number of 
spaces. However, the opposite relationship was seen with genes fyuA and irp2, and no 
association was detected between the number of spacers and the presence of hlyA, 
aidA-1, iha, efa1, efa2, stx1 and stx2 (Data not shown). Interestingly, strains 
containing both stx genes showed significantly fewer spacers than those with only one 
of them (p<0.05) (Fig. III.2d). 
 
3.5.5.I-E subtype cas phylogeny 
To investigate the relationship between CRISPR and the evolutionary history 
of strains, a maximum likelihood phylogenetic tree was reconstructed based on the 




III.3). Strains were grouped into four major clades except E. coli K12 which was used 
as outgroup. All O157:H7 strains formed a single clade, whereas O103:H2 strains 
belonged to another cluster. However, an O103:H25 strain (CVM9340) appeared in a 
separated clade. Interestingly, the remaining strains of serotypes O111:H11, O111:H8 
and O26:H11 all clustered together, indicating a closer phylogenetic relationship and 
more conserved I-E subtype cas alleles among them. 
Additionally, pairwise distance matrix of SNP differences (data not shown) 
supported phylogeny results of maximum likelihood analysis. For example, SNPs 
differences between group H8 and H11, group O103:H25, O103:H2, and group 
O157:H7 were 14, 74, and 100 SNPs, respectively (Fig III.3). 
 
3.6. Discussion 
In this study, the occurrence and content of CRISPR loci in STEC was 
determined, and conservation among strains of the same serotype (O and H antigen 
type combination) but not between serogroups (i.e., only O antigen type) was 
observed. However, in certain cases, strains of different serotypes but with the same 
H type shared identical CRISPR sequences, suggesting such serotypes might have 
common ancestors based on H type but not in O groups (Fig. III.1). This may provide 
a genetic basis for the specific detection and tracking of particular E coli strains in the 
environment or in the food supply. In addition, a significant negative association was 
observed between the number of spacers (an indicator of CRISPR systems activity) 
and the pathogenic potential of STEC strains as indicated by their seropathotype (4) – 




Other studies also demonstrated the relationship between CRISPR array 
content and serotypes. Delannoy et al. reported the presence of specific CRISPR 
polymorphisms related to O:H serotypes of STEC O26:H11; O45:H2; O103:H2; 
O104:H4, O111:H8; O145:H28, and O157:H7 which were useful to differentiate 
these serotypes (33, 34). However, they reported numerous cross reactions: primers 
for O145:H28 reacted with strains O28:H28, and primers detecting O103:H2 and 
O45:H2 altogether also cross-reacted with strains O128:H2 and O145:H2, among 
others (33). These data showed similar CRISPR array characteristics; identical arrays 
were shared by strains of different serotypes having the same H antigen (O26:H11, 
O103:H11, and O111:H11; O45:H2 and O103:H2), and arrays of strains of the same 
serogroups with different H types seemed unrelated (O103:H2 and O103:H11) further 
underscoring the linkage between CRISPR array and H antigen alleles (Fig. III.1). 
Similarly, Yin et al. confirmed a relationship between CRISPR polymorphism and 
serotypes, but also described a strong conservation of CRISPR arrays within isolates 
of the same H type including H7, H2 and H11 (18). A previous study on the 
evolutionary history of non-O157 STEC by WGS showed O26:H11 and O111:H11 
grouped together, also suggesting strains with the same H antigens may have 
common ancestors (31). 
Furthermore, the concatenated sequence of their I-E subtype cas genes did not 
discriminated between strains of the serotypes O26:H11, O111:H8 and O111:H11, 
reflecting close relatedness of those serotypes. Ju et al. also demonstrated strains with 
H8/H11antigens formed a major clade on the whole genome wide phylogenetic tree 




H11was closer to strains of serotype O103:H25 than to strains of O103:H2 based on 
I-E subtype cas sequences. Thus, concatenated I-E subtype cas genes could not be 
used to determine the same phylogenies as found in genomic comparisons among 
serotypes (35). 
The role of CRISPR as an immune system against mobile genetic elements 
has been previously reported (9, 36), and since many virulence determinants are 
acquired through mobile genetic elements (25) it is expected that strains with more 
active CRISPR systems carry less virulence genes and other mobile genetic elements. 
Some studies focused on the role of CRISPR systems in acquisition of virulence 
determinants with contradictory results, notably in E. coli. Specifically, one study 
showed the acquisition of plasmids carrying antimicrobial genes was not related to 
the presence of the CRISPR system (26). In contrast, another study found that 
CRISPR-Cas systems were inversely correlated with the presence of acquired 
antibiotic resistance in E. fecalis strains (37). In Enterococcus spp., an inverse 
correlation between the presence of two virulence genes and the distribution of cas 
genes was reported, and less virulence genes were detected when cas genes were 
present (27). In the present study, it was found that cas genes were not related to the 
presence of virulence markers in STEC (35); however, statistically significant 
differences in the total number of spacers between strains of seropathotype A and 
other seropathotypes indicated the most pathogenic serotypes had less spacers than 
those of other serotypes (Fig. III.2), suggesting a negative correlation between 
CRISPR activity and propensity for pathogenic trait acquisition. This was consistent 




genetic material derived from mobile and invasive elements such as phages and 
plasmids. Similarly, the presence of some virulence genes was related to lower spacer 
content. Notably, when two stx genes were present, strains had significantly less 
spacers than those having one (p<0.05). This would challenge recent studies in E. coli 
suggesting that CRISPR systems would not work as a cell defense system against 
alien genetic elements (21, 38). Conversely, High Pathogenicity Island (HPI) genes 
irp2 and fyuA presented an inverse relationship; however, its contribution to virulence 
seems irrelevant (30).  Therefore, further studies are necessary across a broad range 
of genetic strains to assess the relationship between CRISPR-Cas systems and 
virulence in E. coli. 
Four CRISPR arrays have been identified in E. coli, but all four are rarely 
found in a single isolate (17, 19). Similarly to what was found by Yin et al. (18), data 
in this study showed that the type I-E CRISPR-Cas system (CRISPR1 and CRISPR2) 
was most widely distributed in STEC. One strain (95-3322), however, carried the four 
arrays, and the remaining strains carried a shorter, combined CRISPR3-4 array as 
previously described (19) which is associated with the fusion of the remaining 
sections of loci 3 and 4 when I-F genes, originally located between the two loci, are 
deleted (19). To confirm the absence of I-F cas genes, the region between primers 
C3Fw (clpA target) and C4 Rev (infA target) was sequenced. In most cases, the 
fragment produced was of 800 bp instead of the expected 3000bp when I-F 
subtype cas genes are present (179/190) (19). The absence of cas genes and repeats 
among these motifs would suggest a relatively minor role for CRISPR system I-F in 




Protospacers for 10 CRISPR spacers from STEC were identified. Most 
protospacers (9/10) were located in Salmonella and E. coli plasmids, including 
multiple sequences from the same plasmid (Table III.2), for both CRISPR1 and 
CRISPR2. Additionally, a spacer showing identity with Enterobacteria phage P7 was 
found in 12 out of the 13 strains for which matching protospacers were identified 
(Table III.2). Yin et al. also observed multiple spacer sequences originated from the 
same origin (18), and previously Datsenko et al. demonstrated that mutated motif 
stimulates the acquisition of more spacers from the same target to strengthen 
immunity against the element (39). 
3.7. Conclusion 
The current study provides novel insights into the occurrence and role of 
CRISPR-Cas systems in STEC serogroups (O26, O103 and O111) as well as several 
additional uncommon serotypes. CRISPR array sequence analysis suggests H antigen 
might have been acquired more ancestrally than O antigen since arrays are shared by 
strains with the same H antigen but not among strains with the same O antigen. 
Alternatively, stability among H antigens in STECs may also point to a more vertical 
inheritance pattern and less promiscuity than O antigen evolution, known to be 
dappled by numerous horizontal gene transfer events throughout its radiation in E. 
coli (40). Also, the relationship between CRISPR elements and pathogenicity traits in 
STEC needs to be studied to determine whether they have a causal relationship or 
whether a formal balancing selection drives acquisition of the two. Further studies 
using additional and genetically diverse strains would provide a better understanding 




genetic markers could be used to differentiate high risk STEC from low risk strains, 
thereby provide useful tools for the control of STEC infections, and insights into their 
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3.9. Figures and Tables 
 















Left block represent CRISPR1 and right block represents CRISPR2 for the same 
strains in the same order. Only spacers are shown and are represented by colored 
squares. Same color/figure combination represents same nucleotide sequence. Spacers 
located to the right are older spacers, and spacers located to the left are newer spacers. 
Column labeled “L” indicates leader sequence position. Red strain names indicate 
anchor strain. Sequences were extracted using a proprietary macro designed by 
DuPont. Same software was used for the representation of spacers and repeats (28). 






Figure III.2. Total spacer content depending on strain seropathotype, ability to cause 
outbreak, severe disease, and stx genes content. 
 
Bars represent total spacer count (CRISPR1, CRISPR2a and CRISPR2b, CRISPR3-4, 
and CRISPR 3 and CRISPR4) by a) each of the five seropathotypes, b) potential 
ability to cause outbreak and c) potential ability to cause severe disease based on 
Karmali classification (4) and d) stx genes content. Lines represent ±2 standard error. 
Statistic tests revealed significant differences (p<0.05) between seropathotypes. 
Significant differences (p<0.05) were also detected between ability to cause 








Concatenated sequences of type I-E cas genes (cas1, cas2, cas3’, cse1, cse2, cas6e, cas7, cas5) were obtained from a previous 
sequencing project (31) (16 strains) and publically available sequences for 8 E. coli. Maximum likelihood phylogenetic tree based 




Table III.1: O group and H type, year of isolation and Origin of strains used in 
CRISPR study 
Strain O Group H type Year Isolation Origin 
1880 55 7 - - 
CVM_10001 26 11 1993 Human 
CVM_10008 26 11 1993 Human 
CVM_10014 26 11 1994 - 
CVM_10017 26 11 1995 Cow 
CVM_10040 26 11 1995 Human 
CVM_10110 26 11 1997 Cow 
CVM_10128 26 11 1997 Human 
CVM_10129 26 11 1997 Human 
CVM_9260 103 2 2000 Deer 
CVM_9301 103 2 1987 Goat 
CVM_9318 103 2 1990 Cow 
CVM_9322 103 2 1990 Cow 
CVM_9328 103 2 1992 Human 
CVM_9380 103 2 1996 Human 
CVM_9385 103 2 1996 Human 
CVM_9397 103 2 1997 Cow 
CVM_9398 103 2 1997 Cow 
CVM_9400 103 2 1997 Cow 
CVM_9410 103 2 1997 Cow 
CVM_9415 103 2 1997 Cow 
CVM_9422 103 2 1997 Cow 
CVM_9434 103 - 1997 Cow 
CVM_9439 103 2 1997 Human 
CVM_9449 103 2 1999 Human 
CVM_9453 103 2 1999 Human 
CVM_9460 111 8 2000 Cow 
CVM_9464 111 8 2000 Cow 
CVM_9467 111 8 1976 Cow 
CVM_9505 111 11 1987 Cow 
CVM_9519 111 11 1987 Cow 
CVM_9529 111 11 1987 Cow 
CVM_9536 111 8 1988 - 
CVM_9556 111 - 1990 Cow 
CVM_9557 111 8 1990 Cow 




Strain O Group H type Year Isolation Origin 
CVM_9571 111 8 1993 Cow 
CVM_9579 111 8 1993 Human 
CVM_9585 111 8 1995 Cow 
CVM_9587 111 8 1995 Cow 
CVM_9591 111 11 1995 Cow 
CVM_9592 111 8 1995 Human 
CVM_9596 111 8 1996 Cow 
CVM_9608 111 8 1997 Cow 
CVM_9610 111 8 1997 Cow 
CVM_9611 111 8 1997 Cow 
CVM_9617 111 8 1997 Cow 
CVM_9619 111 8 1997 Human 
CVM_9647 111 8 1999 Cow 
CVM_9650 111 8 1999 Human 
CVM_9658 128 2 2000 Sheep 
CVM_9659 128 2 2000 Sheep 
CVM_9790 145 28 1995 Human 
CVM_9818 111 - 1997 Cow 
CVM_9892 26 11 2000 Cow 
CVM_9935 26 11 1981 Antelope 
CVM_9939 26 11 1982 Cow 
CVM_9945 26 11 1984 Cow 
CVM_9953 26 11 1985 Pig 
CVM_9965 26 11 1988 Cow 
CVM_9985 26 11 1991 - 
CVM_9988 26 11 1992 Cow 
CVM_9995 26 11 1993 Human 
CVM_9997 26 11 1993 Human 
CVM_9998 26 11 1993 Human 
ESC0589 NT - 2007 Produce 
ESC0592 NT - 2008 Produce 
ESC0593 45 2 2008 Produce 
ESC0599 NT 52 2004 Produce 
ESC0601 121 19 2004 Produce 
ESC0620 NT - - Produce 
K46A236a 8 30 - - 
K47A282a 8 2 - - 




Strain O Group H type Year Isolation Origin 
MI4 45 2 - - 
SJ13 111 NM - - 
SJ4 2 25 - - 
TW_7920 103 2 - - 
UMD131 OR 9 - Human 
UMD137 9 - - - 
UMD141 26 11 - Calf 
UMD144 45 2 - - 
UMD146 55 7 - - 
UMD161 103 2 - Human 
UMD162 103 2 - Steer 
UMD163 103 2 - Calf 
UMD164 111 NM - Human 
UMD168 111 NM - Calf 
UMD204 91 21 - Sheep 
UMD206 5 NM - Sheep 
WT119-2 91 14 2009 Pork 
WT126-1 91 7 2009 Beef 
WT380-3 NT - 2009 Pork 
WT396-5 91 - 2009 Pork 
XDN4854 NT 10 2005 Beef 
XDN5545 NT 7 2005 Beef 
XDN5578 NT 46 2005 Beef 
90.0327
a
 22 8 - Cow 
97.0077
a
 118 - - - 
971
a
 26 11 - - 
1387
a
 111 8 - Calf 
1659
a
 157 7 - Human 
4162
a
 103 6 - - 
5645
a
 45 2 - - 
5906
a
 55 7 - - 
7865
a
 145 28 - Human 
8023
a
 121 19 - - 
493/89
a
 157 NM 1989 Human 
5412/89
a
 157 NM 1989 Human 
90-3158
a
 146 21 - - 
94-3024
a
 104 21 - - 




Strain O Group H type Year Isolation Origin 
95-3322
a
 22 5 - - 
96-3305
a
 128 45 - - 
AA1
a
 174 8 - - 
CVM_9320
a
 103 11 1990 Cow 
CVM_9338
a
 103 2 1993 Human 
CVM_9353
a
 103 25 1995 Cow 
CVM_9354
a
 103 25 1995 Cow 
CVM_9530
a
 111 11 1987 Pig 
CVM_9648
a
 111 8 1999 Cow 
CVM_9652
a
 128 16 2000 Okapi 
CVM_9653
a
 128 16 2000 Okapi 
CVM_9763
a
 128 16 1999 Okapi 
CVM_9785
a
 145 28 1995 Cow 
CVM_9903
a
 26 11 1977 Cow 
EC96012
a
 157 7 1996 Human 
EC96038
a
 157 7 1996 Human 
EC97144
a
 157 7 1997 Human 
ESC0603
a
 36 14 2006 Produce 
ESC0608
a
 73 18 2009 Produce 
ESC0609
a
 116 21 2009 Produce 
ESC0610
a
 113 36 2009 Produce 
ESC0613
a
 168 8 2009 Produce 
ESC0615
a
 113 21 2009 Produce 
FDA413
a
 157 7 - - 
H1085C
a
 157 NM 2003 - 
H2687
a
 157 NM 2003 - 
H56909
a
 157 NM 1999 - 
MI3
a
 45 2 - - 
SJ12
a
 103 11 - - 
SJ18
a
 121 17 - - 
SJ20
a
 128 2 - - 
SJ23
a
 145 NM - - 
SJ29
a
 113 21 - Human 
SJ3
a
 26 11 - - 
SJ31
a
 113 21 - - 
SJ9
a
 45 2 - - 
TW_08087
a
 145 28 - Human 




Strain O Group H type Year Isolation Origin 
TW_08868
a
 121 19 1999 Human 
TW_7990
a
 103 2 - - 
UMD135
a
 5 NM - - 
UMD142
a
 26 11 - - 
UMD145
a
 46 38 - Beef 
UMD159
a
 88 49 - Beef 
UMD160
a
 91 21 - Cow 
UMD165
a
 111 8 - Calf 
UMD166
a
 111 11   Calf 
UMD167
a
 111 11 - Calf 
UMD170
a
 113 21 - Human 
UMD173
a
 125 NM - - 
UMD217
a
 50 7 - - 
WT219-5
a
 91 14 2009 Pork 
WT348-1
a
 91 14 2009 Pork 
WT419-1
a
 91 14 2010 Pork 
XDN11682
a
 83 8 2006 Beef 
XDN15018
a
 15 27 2007 Beef 
XDN15432
a
 83 8 2007 Beef 
XDN20177
a
 8 16 2002 Beef 
XDN23765
a
 NT 2 2003 Beef 
XDN2688
a
 88 38 2004 Beef 
XDN2746
a
 83 8 2004 Beef 
XDN5789
a
 15 16 2005 Beef 
CVM_9340
ab
 103 25 1993 Human 
CVM_9534
ab
 111 11 1988 Cow 
CVM_9574
ab
 111 8 1993 Human 
EC4115
ab
 157 7 2006 Human 
Sakai
acb
 157 7 1996 Human 
TW14359
ab
 157 7 2006 Human 
CVM_10021
b
 26 11 1995 Cow 
CVM_10026
b
 26 11 1995 Cow 
CVM_10030
b
 26 11 1995 Cow 
CVM_10224
b
 26 11 1997 Human 
CVM_9450
b
 103 - 1999 Human 
CVM_9455
b
 111 - 2000 - 
CVM_9545
b
 111 11 1988 Cow 




Strain O Group H type Year Isolation Origin 
CVM_9553
b
 111 11 1990 Cow 
CVM_9570
b
 111 8 1993 Cow 
CVM_9602
b
 111 8 1996 Human 
CVM_9634
b
 111 8 1998 Cow 
CVM_9942
b
 26 11 1983 Cow 
CVM_9952
b
 26 11 1985 Cow 
EDL933
b
 157 7 1982 Beef 
11128
bc
 111 - 2001 Human 
11368
bc
 26 11 2001 Human 
12009
bc
 103 2 2001 Human 
K12
bc
 OR 48 - - 
 
 
-: Data not available. 
a
: used for CRISPR and pathogenicity study 
b
: Used for cas genes sequencing study 
c






Table III.2. General characteristics of CRISPR arrays from E. coli (n=195) 
 
Characteristic CRISPR1 CRISPR2a CRISPR2b CRISPR3 CRISPR4 CRISPR3-4 
Number of isolates 
with array 
195 195 186 1 1 193 
Number of Unique 
arrays 
78 79 6 1 1 6 
Spacers in array       
Range 1-20 1-20 0-1 11 6 1-13 
Average 9 7 1 11 6 1 
Mode 5 7 1 11 6 1 
       
Total spacers 1612 1349 157 11 6 218 
Different spacers 258 230 1 11 6 22 
Unique spacers 
Spacers Length (bp) 
128 123 0 11 6 15 
Average 32 32 32 32 32 32 
Min 31 30 32 32 32 28 
Max 34 35 32 32 33 34 
Protospacers 
detected 










Hits Description E-value 
CCAAATAGTCCCCAACATCCTGCCGTAAATAT 
 
C1 CP003279.1 S. Typhi str. P-stx-12 plasmid 3.00E-08 
 
  AM412236.1 
 




  AF250878.1 
 











  CP003279.1 
 









  AF503408.1 
 











  AP010961.1 
 





  AM412236.1 
 
S. Paratyphi A IncH1 multiple 





  DQ449578.1 
 
K. pneumoniae strain NK245 
plasmid pK245 
3.00E-08 
  AF239689.1 
 









Hits Description E-value 
  AF250878.1 
 
S. Typhi R27 plasmid 
 
3.00E-08 
  AL513383.1 
 











  CP000966.1 
 








S. Typhi str. P-stx-12 plasmid 3.00E-08 
 
  AM412236.1 
 
S. Paratyphi A IncH1 multiple 




  AF250878.1 
 







S. Typhi str. P-stx-12 plasmid 3.00E-08 
 
  AP010961.1 
 
E. coli O111:H- str. 11128 
plasmid pO111_1 DNA 
3.00E-08 
  AB366440.1 
 
S. Choleraesuis plasmid pMAK1 
strain: L-2454 
3.00E-08 
  AM412236.1 
 
S. Paratyphi A IncH1 multiple 
drug resistance 
3.00E-08 
  AF250878.1 
 
S. Typhi R27 plasmid 3.00E-08 
  AL513383.1 
 





















Hits Description E-value 
  AP010961.1 
 




  AB366440.1 
 




  AM412236.1 
 




  AF250878.1 
 
Salmonella Typhi R27 plasmid 3.00E-08 
 
  AL513383.1 
 








S. Typhi str. P-stx-12 plasmid 3.00E-08 
 
  AP010961.1 
 




  FJ183736.1 
 
S. Typhi plasmid IncHI1 




  FJ183735.1 
 
S. Typhi plasmid IncHI1 




  AB366440.1 
 
S. Choleraesuis plasmid pMAK1 




  AM412236.1 
 




  AF250878.1 
 


































  JX627737.1 
 








  JX445149.1 
 




  CP003290.1 
 
E. coli O104:H4 str. 2011C-
3493 plasmid pESBL-EA11 
3.00E-08 
 
  JF927996.1 
 
E. coli plasmid pXZ 3.00E-08 
 
  JQ432559.1 
 
E. coli plasmid pHK23a 3.00E-08 
 
  FR851303.1 
 





  JF274993.1 
 




  JN232517.1 
 




  CP002732.1 
 











































  FJ664747.1 
 
E. coli strain TA445 plasmid 
colBM colicin M gene cluster; 
cma gene, partial sequence; 
colicin B gene cluster, complete 
sequence; and colicin B activity 
3.00E-08 
 
  M16816.1 
 
Plasmid pF166 (from E.coli) cba 








Table III.4. Location of spacers with protospacers in STEC strains. 
Strain Serotype CRISPR Length of the array Number Spacers with 
Protospacers 
Location in the array 
(from leader sequence) 
90_0327 O22:H8 1 11 2 2 7   
95_3322 O22:H5 1 9 1 2    
  3 11 1 1    
  4 6 1 6    
ESC_0589 NT 1 7 2 2 3   
ESC_0608 O73:H18 1 12 1 2    
ESC_0613 O168:H8 1 7 1 2    
UMD_131 OR:H9 2 12 3 10 11 12  
XDN_11682 O83:H8 1 3 1 2    
XDN_15432 O83:H8 1 10 2 7 2   
XDN_23765 ONT:H2 1 6 1 2    
XDN_2746 O83:H8 1 3 1 2    
XDN_4854 ONT:H10 1 19 5 2 8 17 19 
  2 8 1 8    
XDN_5545 ONT:H7 1 19 4 2 7 17 19 






Chapter 4: CRISPR ARRAY IN Salmonella enterica subspecies 
enterica (S. enterica). 
4.1 Abstract 
CRISPR arrays of 221 strains of Salmonella enterica subspecies enterica (S. 
enterica) of 53 serotypes were sequenced and analyzed for spacer content to define 
their relationship with serotype. In deep study of the CRISPR-cas system in 50 S. 
enterica serotype Bareilly (S. Bareilly) strains was performed to understand intra 
serotype variations. It was found that both CRISPR arrays (CRISPR1 and CRISPR2) 
correlate well with serotypes in S. enterica, although some serotypes displayed more 
than one type of array. Two types of CRISPR2 arrays in S. Bareilly were found, 
demonstrating intra serotype variation when increasing the sample size. Additionally, 
it was found that CRISRP-cas system reflects S. Bareilly phylogeny similar to MLST, 
notably cas genes, but a link between array information to food of isolation or 
geographical origin of the isolate was not found. In conclusion, CRISPR array would 
be useful for designing of molecular serotyping assays, but a wider range of strains 





Salmonella enterica subspecies enterica (S. enterica) causes over one million 
diseases every year in the U.S, and is one of the most prevalent foodborne pathogens 
in the world (1). Frequently associated to foodborne outbreaks (1), it has been 
isolated from diverse types of food and environments (2); serotypes Enteritidis, 
Typhimurium, Newport, and Javiana are the most frequently associated to illnesses in 
the US (3), but over 1500 S. enterica serotypes are described to date (4). 
Serotyping is one of the most used tools in outbreaks investigations (5), 
however, traditional serotyping may take over five days (6), it is common to find 
untypable serotypes (7), and it requires the production of hundreds of antisera in 
laboratory animals (6). As an alternative, molecular typing methods deliver similar 
results in reduced time (6, 8, 9); therefore, the identification of new molecular 
markers is fundamental to develop new and improved typing methods which will help 
to improve public health (10). 
Recently, a new potential marker has been described: CRISPR-cas systems. 
They are putative bacterial immune systems (11, 12) that consist of three parts; an 
array formed by a variable number of repeats (29 nt repeated sequences) intersperse 
with spacers (non-repeated short sequences), a group of genes codifying for CRISPR 
associated proteins (cas), and a leader sequence with the promoter for transcription 
(13). Spacers would be acquired from foreign genetic elements –such as plasmids and 
phages— and incorporated into the array after a failed infection (14, 15). They would 
work as probes that detect and prevent an infection with a previously known mobile 




element, inactivating it (13, 15, 16). Since invasions and immunization events depend 
on the bacterium environment, spacer content should be variable depending on the 
ecological environment where a lineage evolved (17, 18). This characteristic could be 
used to differentiate isolates from different origin, or to describe different cell 
lineages (12, 19). 
Some authors described E. coli and Salmonella CRISPR arrays as slow 
evolving systems (20), but other studies concluded CRISPR arrays could be 
potentially used for serotyping of Shigatoxin producing Escherichia coli (STEC) and 
Salmonella (21-23); however, the variation of CRISPR arrays across Salmonella 
serotypes is not fully understood. Also, CRISPR-cas system differences among 
strains of the same serotypes are not fully explored, especially for some emerging 
serotypes such as Salmonella enterica subspecies enterica serotype Bareilly (S. 
Bareilly) which recently reached the CDC top 15 Salmonella serotypes that most 
frequently cause human disease (3). 
The hypothesis in this study were that CRISPR arrays differ between 
serotypes, and that variations might also be found among strains of the same serotype. 
Also, that different components of the CRISPR-cas system might reflect the 
phylogeny of a strain in a serotype. To answer these questions, CRISPR arrays for 53 
different Salmonella serotypes were sequenced and characterized, and the CRISPR-






To characterize S. enterica CRISPR’s arrays in selected serotypes and the CRISPR 
system of S. Bareilly. 
 
4.4 Materials and Methods 
4.4.1. Strain collection 
A total of 221 S. enterica were selected from FDA Salmonella culture 
collection. Strains from 53 different serotypes were used to study CRISPR array inter 
serotypes differences (Table IV.1). 
To study CRISPR-cas systems intra serotype variation, 50 S. Bareilly strains 
with different PFGE pattern were used. Strains were isolated in different dates, 
sources and geographic locations (Table IV.2). 
 
4.4.2. DNA isolation 
DNA was isolated using InstaGene matrix (Bio-Rad, Hercules, CA) following 
manufacturer instructions. Briefly, 1 to 2 colonies were suspended in 1 ml of 
ultrapure water. Suspension was centrifuged and supernatant discarded. Then, 200ul 
of Instagene matrix were added, and the suspension was incubated first at 56°C for 30 
minutes, and then at 100°C for 8 minutes. The suspension was centrifuged, and the 





4.4.3. PCR and DNA sequencing Salmonella enterica serotypes 
CRISPR1 and CRISPR2 were amplified and sequenced using previously 
described primers (24) (Table IV.3). PCR conditions included an initial denaturation 
at 95°C for 10 minutes and 28 cycles of denaturation at 94°C, annealing at 55°C, and 
1:30 sec of elongation at 72°C, plus a final elongation at 72°C for 15 minutes, and 
infinite hold at 4°C. 
PCR products were sequenced by MCLAB (San Francisco, California) with 
the same group of primers (Table IV.3). Additionally, internal primers were designed 
to sequence longer DNA arrays for the following serotypes: Bareilly, Braenderup, 
Heildelberg, Montevideo, Muenster, Newport, Seftenberg, Tennessee, and 
Typhimurium (Table IV.3). 
 
4.4.4. CRISPR array detection, extraction and analysis 
CRISPR array sequences were assembled from at least one forward and one 
reverse read using Geneious v.6.15 created by Biomatters. Additional internal 
readings were used for some isolates. 
CRISPR sequences were individually extracted using a Macro tool designed 
by DuPont. The program identifies repeats and spacers, and also creates a graphic 
representation of spacers and repeats as previously described (25). 
CRISPR arrays were manually organized in clusters based on the presence of 
common consecutive repeats and spacers from the distal end to the leader sequence. 
Anchor strains –strains with the longest series of spacers and arrays in a group of 




4.4.5. Protospacer analysis 
Each one of the spacers detected was compared against NCBI phages and 
plasmids database (January 2013) with the BLAST plug in utility from Geneious 
v6.15 (26). Protospacers were homologous sequences with an e value <1.10e-5 and 
less than 10% difference in sequence length (27). Matches to CRISPR sequences 
were omitted. 
 
4.4.6. I-E cas system analysis of Salmonella Bareilly 
I-E cas genes from S. Bareilly were extracted from whole genome sequences 
data provided by FDA. Genes were extracted using the BLAST add on installed in 
Geneious 6.5.5 (26). cas genes were concatenated in the following order: cas1, cas2, 
cse3, cse5e, cse4, cse2, cse1 and cas3; low quality and partial sequences were 
excluded from the analysis. Then, sequences were aligned with Clustal W (28) plug 
in for Geneious with default options, and a consensus phylogenetic tree was crafted 
using Jukes Kantor model with the Neighbor-joining method, with 1,000 replications. 
S. Typhi CT18 was selected as outgroup. Additionally, leader sequences for both 
CRISPR arrays were extracted and analyzed. Alignment and phylogenic tree were 





4.4.7. Salmonella Bareilly phylogenetic tree with Multilocus Sequence Typing 
(MLST) genes. 
To understand the relationship between the CRISPR-cas system and 
phylogenetic evolution of the strains, housekeeping genes for Salmonella enterica 
(aroC, dnaN, hemD, hisD, purE, sucA, and thrA), which reflect phylogeny (29), were 
extracted from the whole genome sequence and concatenated using Geneious. 
Sequences were aligned with Clustal W (28) plug in for Geneious with default 
options, and a consensus tree was constructed with 1,000 bootstrap iterations, and S. 
Typhi CT18 was used as outgroup. 
 
4.4.8. S. Bareilly antimicrobial resistance test 
Antimicrobial minimum inhibitory concentrations (MIC) of Salmonella 
Bareilly isolates were determined via Sensitre automated microbial susceptibility 
system (Trek Diagnostic system, Westlake, OH) and interpreted according to the 
CLSI MIC Interpretative standards. Escherichia coli ATCC 35218, Enterococcus 
faecalis ATCC 29212, Staphyloccoccus aureus ATCC 29213 and Pseudomonas 
aeruginosa ATCC 27853 were used as controls in antimicrobial MIC determinations. 
The following antimicrobials were tested: Amikacin (Ami), Amoxicillin/clavulanic 
acid (Aug), Ampicillin (Amp), Cefoxitin (Fox), Ceftiofur (Tio), Ceftriaxone (Axo), 
Chloramphenicol (Chl), Ciprofloxacin (Cip), Gentamicin (Gen), Kanamycin (Kan), 
Nalidixic acid (Nal), Streptomycin (Str), Sulfamethoxazole (Smx), Tetracycline (Tet), 






In this study, CRISPR arrays of 221 Salmonella enterica strains of 53 
serotypes were described, and CRISPR-cas system of 50 strains of S. Bareilly were 
characterized. 
 
4.5.1 CRISPR array in Salmonella sp. 
Arrays CRISPR1 and CRISPR2 were present in all 241 screened strains, as 
previously described (20, 30). Arrays were manually organized based on the presence 
of common, consecutive spacers. As a consequence, organization based on CRISPR1 
also organized arrays in CRISPR2 (Figure IV.1). 
CRISPR1 displayed longer arrays than CRISPR2 (Fig. IV.1). S. enterica 
serotype Muenster CRISPR1 array reached 62 spacers, while the longest CRISPR2 
array only had 37 spacers (S. enterica serotype Kentucky) (Fig. IV.1). Moreover, the 
average length of CRISPR1 was longer than CRISPR2, although array length and 
content varied depending on serotypes (Fig. IV.2, Fig. IV 3, and Table IV.4). 
A universal anchor strain in CRISPR1 or CRISPR2 was not identified, but 
some arrays could be used as anchors for some clusters. In general, same serotype 
strains clustered together, and their arrays differed only based on spacer/repeats 
deletions but not in their sequences; For example, every S. enterica serotype Agona 
strain had exactly the same sequence in CRISPR1, and a half of strains lacked only 
one spacer in CRISPR2 (4/7). Most S. enterica serotype Montevideo were identical in 
CRISPR1 (18/22) and 21/22 were identical in CRISPR2 as well. On the other hand, 




enterica serotype Newport presented 2 types of arrays that did not share any spacer in 
CRISPR1 or CRISPR2 (Fig IV.1), as well as S. enterica serotype Muenchen (Fig. IV. 
1). 
 
 Strains of different serotypes generally displayed different arrays, often 
forming individual clusters; however, some serotypes also shared some spacers 
among them; in CRISPR2 S. enterica serotypes Agona, Abony and Tallahassee 
shared the two older spacers, and their first spacer was also present in S. enterica 
serotype Tennessee. S. enterica serotypes Braenderup, Virchow, and Anatum shared 
two ancestral spacers, and the former also had five other spacers in common. (Fig 
IV.1). A cluster of strains formed by S. enterica serotypes Newport, Typhimurium, 
and Heildelberg shared the three older spacers, and additionally, they also had other 
common spacers in different positions, indicating deletions of spacers. 
Although CRISPR1 co-clustered with CRISPR2, organization deferred some 
times. For example, S. enterica serotype Tallahassee did not share any spacer with S. 
enterica serotype Agona and Abony in CRISPR1, and S. enterica serotype Newport 
displayed totally different arrays from S. enterica serotypes Typhimurium and 
Heidelberg in CRISPR1 (Fig IV.1). 
 
4.5.2 CRISPR array in Salmonella Bareilly. 
S. Bareilly CRISPR arrays were organized in two different groups. CRISPR1 
showed almost the same spacers in the same order for all the strains, but some 
differences were observed due to spacer deletion. Oppositely, CRISPR2 arrays 




Strain SAL2887 was identified as an anchor strain for group A, but an anchor strain 
for group B could not be identified since 24/26 strains displayed identical arrays (Fig. 
IV.4). When organizing strains based on CRISPR2 arrays, almost every group B 
strain lacked the last, newer 4 spacers in CRISPR1 (23/24), and those strains also 
presented a difference sequence in the first, more ancestral repeat (Fig IV. 4). 
Interestingly, strain SAL2890 presented pattern more similar to group A in CRISPR2 
while grouped with cluster B based on CRISPR 1 organization (Fig IV.4). 
A relationship between the type of array and other strain’s characteristics such 
as type of food the strain was isolated from or geographical origin was not identified. 
Moreover, antimicrobial resistance test indicated all S. Bareilly strains were 
susceptible to every antimicrobial tested; therefore, a potential relationship between 
CRISPR and this characteristic was not suitable for study. 
 
4.5.3. Spacers diversity 
A total of 6744 spacers in Salmonella enterica CRISPR arrays were found; 
19% of spacers were different, and 8.9% were present only once (Table IV.3). 
Spacer’s average length was 32 bp in both arrays, but CRISPR 1 spacers had 
more range of variation (30 to 44 bp) than CRISPR2 (Table IV. 3). Interestingly, six 
spacers were present in both loci. Protospacers for 20 spacers were found; all of them 
were originated from phage. 
Strains of Salmonella Bareilly displayed over 1800 spacers, but only 55 were 




only 1 bp difference between the longest and the shortest spacer, and we detected 
only one protospacer, which had identity with a phage (Data not shown). 
Some strains also presented some insertion sequences that were not identified 
as spacers in their arrays; strains S. enterica serotypes Typhimurium and Heildelberg 
presented a 13 nt sequence in the middle of CRISPR1 arrays (position 10, aprox), and 
some of the S. enterica serotype Paratyphi B strains displayed the same insertion. S. 
enterica serotype Kentucky displayed a 50 nt insertion in position 7 out of 20 spacers 
also in CRISPR1. No insertions were detected in CRISPR2, however, a G residue 
intercalated 2 repeats in some S. enterica serotype Newport strains (Figure IV.1). 
 
4.5.4. S. Bareilly phylogeny based on Multi locus sequence type genes and 
CRISPR system. 
Concatenated sequences of S. Bareilly housekeeping genes (aroC, dnaN, 
hemD, hisD, purE, sucA, and thrA) arranged in two different clusters (Fig. IV.5). 
Seventy 70 SNPs were identified which were present across all genes sequences with 
frequencies of 6 (aroC), 13 (dnaN), 7 (hemD), 2 (hisD), 28 (purE), 8 (sucA), and 6 
(thrA) (data not shown). 
S. Bareilly concatenated cas genes (cas1, cas2, cse3, cse5e, cse4, cse2, cse1 
and cas3) clustered in a two-branch phylogenetic tree (Fig. IV.6) as well as the leader 
sequence for array CRISPR2 (Fig IV.7). cas genes for 39 out of the 41 analyzed 
strains presented only 6 SNPs among them. However, two strains (2917 and 2923) 




CRISPR1 leader sequence (Fig IV.8) showed polytomy due to a 100% of sequence 
conservation among S. Bareilly strains, and no SNPs were detected. 
Agreement between housekeeping genes and CRISPR systems clusters was 
correct in 46 out of the 48 cases analyzed; strains clustering in MLST group A also 
grouped together in cas genes, leader sequence2 and CRISPR2 groups A. Salmonella 
Bareilly strains 2890 and 2892 showed disagreement in their grouping: Strain 2890 
classified as group A for housekeeping genes, but it did not group with other strains 
in by cas genes tree, and displayed the same distance from both groups However, this 
strain CRISPR array clustered in group A and leader sequence group A. Interestingly, 
strain 2892 grouped in cluster A for housekeeping genes, but its complete CRISPR-
cas system grouped into cluster B. 
 
4.6 Discussion 
In the present work, it was found that CRISPR arrays of S. enterica strains 
correlate well with their serotype, and that some serotypes present more than one type 
of array. As a consequence, it was confirmed that these sequences are useful to design 
molecular serotyping techniques. Additionally, it was concluded that S. Bareilly 
phylogeny is reflected by their CRISPR-cas system. Notably, cas genes cluster in a 
similar fashion that housekeeping genes do. This information could help to 
understand the evolution of the CRISPR-cas system in S. Bareilly and be used as an 
example for the study of the system in other Salmonella serotypes. The composition 
of the CRISPR array was not linked to geographical regions or type of food the S. 




to conclude that CRISPR arrays do not provide enough information for foodborne 
outbreaks tracking. S. Bareilly did not display antimicrobial resistance. This is the 
first report on S. Bareilly strains diversity. 
Other studies have described that CRISRP arrays in Salmonella enterica are 
highly conserved at serotype level (23), and therefore they can be used to detect, 
identify and distinguish Salmonella serotypes; however, information in the loci is not 
enough to differentiate at the strain level (23, 31). Previously, Lui et al. (24) analyzed 
171 strains from the nine most common S. enterica serotypes and concluded that it is 
necessary to include additional genetic markers to differentiate S. enterica to the 
strain level. This study included a more complete range of serotypes (over 200 strains 
from 53 S. enterica serotypes), and as a result, it was found a more diverse range of 
arrays. Liu et al. found arrays ranging from 2 to 25 spacers in CRISPR1 and 
CRISPR2. Array length reached of up to 88 spacer’s (Figure IV.1). Also, they found 
166 and 188 unique spacers in their collection for CRISPR1 and CRISPR2 
respectively, and over 300 unique spacers were found in both loci. It is expected that 
increasing the range of strains included in the analysis will raise a more diverse arrays 
and spacer’s variety. Fricke et al. (30) also concluded that array content correlated 
well with serotypes, and that phylogenetic distances in Salmonella are partially 
reflected in the CRISPR array: they described that S. enterica serotype Newport and 
S. enterica serotype Saintpaul strains presented more than one type of arrays. S. 
enterica serotype Newport and S. enterica serotype Muenchen presented two types of 
array; different lineages have been previously reported based on MLST and whole 




serotype Muenchen phylogenetic diversity have not been previously reported. As a 
conclusion, CRISPR arrays could be used to differentiate strain serotype, however, a 
larger database is necessary to include a higher range of intra serotype variation. 
The diversity of S. Bareilly has not been addressed in literature yet. This work 
was focused on their CRISPR-cas system to determine whether it helps to 
discriminate between strains with different PFGE profiles (data not shown). 
CRISPR1 presented only one sequence patterns, while CRISPR2 showed two 
different profiles; therefore, CRISPR arrays were not as discriminating as PFGE. 
Moreover, it was discovered CRISPR array profiles could not be associated to the 
isolate geographical origin or food of recovery. The relationship between other 
CRISPR-cas system components and strain phylogeny as defined by housekeeping 
genes was also studied (29). cas genes and CRISPR2’s leader sequence presented a 
phylogenetic organization similar to that presented by housekeeping genes. Since 
CRISPR1’s leader sequence and array were non variable, they were not suitable to 
define phylogenies. 
Di Marzio et al. (34) studied the relationship between antibiotic resistance in 
Salmonella Typhimurium and CRISPR sequence. They found an association between 
different types of CRISPR-MLVA alleles for some antimicrobial resistance 
phenotypes, but the evolution rate of CRISPR did not evolve as fast as antimicrobial 
resistance. They conclude that antimicrobial resistance is not directly mediated by 
CRISPR. In this study, all the strains were susceptible to all the antimicrobials tested, 
therefore, the relationship could not be analyzed. Studies in S. Bareilly antimicrobial 




resistance to antimicrobials (Ampicillin, Chloramphenicol, Sulfamethoxazole, and 
Tetracyclin) (35), and it showed high levels of resistance against Tetracycline 
(83.3%), Neomycin (50%) and Streptomicyn (16.7%) when isolated from pasture 
raised chicken in the US (36). In India, seafood isolates from 2003 to 2007 of S. 
Bareilly were susceptible to all antimicrobials tested (Ampicillin, Nalidixic acid, 
Ciprofloxacin, Chloramphenicol, Gentamicyn, Sulfamethizol, Cephalexin, 
Streptomycin, Kanamycin, Oxytetraciclyn and Carbenicillin) (37), and plasmid 
related to antimicrobial resistance were not detected in these strains. Similarly, 
studied strains did not display antimicrobial resistance to any antimicrobial tested. 
Consistently with these results, most of the samples came from south Asian countries 
(43/50), explaining at least partially these results. It would be interesting to study the 
genetic make-up of these strains, especially for plasmids contain to understand why 
these strains do not display antimicrobial resistance. 
The presence of serotypes with more of one CRISPR array pattern may raise 
questions about serotyping misclassification. In a simultaneous study, many studied 
strains were subject to whole genome sequencing, and S. enterica serotype Muenchen 
strains demonstrated that they were correctly classified at a whole genome level (data 
not shown). On the other hand, serotypes with only one type of array might be the 
result of a highly skewed sample: most serotypes were underrepresented with only 
one strain in the analysis. Other authors have also found one general CRISPR array 
pattern for each serotype, but it cannot be discarded that those results are due to an 
incomplete sampling. Based on the findings in S. Bareilly CRISPR arrays, future 




different serotypes but also from different geographic areas, foods origin, and hosts to 
include the whole range of array variation to create am more complete database. This 
is of special importance in the current, globalized commerce. 
The use of CRISPR array content as the only information piece for outbreak 
investigation does not seem suitable for S. enterica. Liu et al. (31) developed a 
system adding two virulence genes and achieve enough differentiation. Similarly, it 
would be interesting to determine whether some housekeeping genes could provide 
such as discrimination: Gene purE showed 26 SNPs in a 399 bp. Fragment, and 
sequence dnaN presented 10 SNPs in 500 bp sequence. These two genes are potential 
candidates to evaluate a system that, using CRISPR array information, will accurate 
subtype S enterica serotypes to the strain level. 
 
4.7 Conclusion 
The conclusion of this study indicates that CRISPR arrays reflect serotype 
classification of S. enterica, and therefore would be useful for designing of molecular 
serotyping assays. However, a wider range of strains should be added to the analysis 
to include the whole variation in S. enterica. Also, it was determined that CRISRP-
cas system reflects S. Bareilly phylogeny at a level similar to MLST. However, a 
better understanding of the correlation between CRISPR array and whole genome 
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Figure IV.3. CRISPR 2 array length (spacers) by serotype in Salmonella enterica*. 
 






















Figure IV.5. Maximum likelihood phylogenetic tree based on concatenated sequences 




Concatenated sequences of S. Bareilly housekeeping genes (aroC, dnaN, hemD, hisD, 
purE, sucA, and thrA) were obtained from whole genome sequence. Maximum 
likelihood phylogenetic tree based crafted with Mega 5.1 with 1,000 bootstrap 







Figure IV.6. Maximum likelihood phylogenetic tree based on concatenated sequences 





Concatenated sequences of S. Bareilly type I-E cas genes (cas1, cas2, cse3, cse5e, 
cse4, cse2, cse1 and cas3) were obtained from whole genome sequence. Maximum 
likelihood phylogenetic tree based crafted with Mega 5.1 with 1,000 bootstrap 







Figure IV.7. Maximum likelihood phylogenetic tree based on CRISPR2 Leader 





Leader sequences for CRISPR2 were obtained from whole genome sequence. 
Maximum likelihood phylogenetic tree based crafted with Mega 5.1 with 1,000 






Figure IV.8. Maximum likelihood phylogenetic tree based on CRISPR1 Leader 




Leader sequences for CRISPR1 were obtained from whole genome sequence. 
Maximum likelihood phylogenetic tree based crafted with Mega 5.1 with 1,000 






Table IV.1. Salmonella enterica serotypes and number of strains in CRISPR 
sequencing study.  
 Serotype # strains 
1 4,[5],12:i:- 2 
2 Abaetetuba 1 
3 Abony 1 
4 Agona 7 
5 Anatum 3 
6 Bareilly 1 
7 Berta 1 
8 Braenderup 1 
9 Cerro 2 
10 Chester 1 
11 Choleraseus 2 
12 Derby 1 
13 Dublin 3 
14 Enteritidis 45 
15 Galinarum 1 
16 Gaminara 1 
17 Give 3 
18 Hadar 1 
19 Heidelberg 38 
20 Indiana 1 
21 Inverness 1 
22 Javiana 3 
23 Johannesburg 1 
24 Kentucky 5 
25 Kunzendorf 1 
26 Litchfield 1 




28 Meleagridis 2 
29 Miami 1 
30 Minnesota 1 
31 Montevideo 22 
32 Muenchen 3 
33 Muenster 1 
34 Newport 20 
35 Oranienburg 3 
36 Panama 1 
37 Paratyphi B 6 
38 Paratyphi_A 1 
39 Pomona 1 
40 Poona 1 
41 Pullorum 3 
42 Rissen 1 
43 Rubislaw 1 
44 Saintpaul 3 
45 Scharzengrund 1 
46 Sloterdijk 1 
47 Stanley 1 
48 Tallahassee 1 
49 Tennessee 2 
50 Thompson 2 
51 Typhimurium 9 
52 Urbana 1 
53 Virchow 1 




Table IV.2. Salmonella Bareilly isolates for CRISPR study 
ID Date of 
Isolation 
Source Country 
SAL2876 7/29/1997 Whisker fish Vietnam 
SAL2877 7/11/1998 Frozen undeveined shrimp India 
SAL2879 12/22/1998 Frozen raw whole fish Vietnam 
SAL2880 12/26/1998 Frozen shrimp India 
SAL2881 5/12/1999 Frozen raw shrimp India 
SAL2882 2/25/2000 Frozen Raw Peeled Shrimp India 
SAL2883 8/7/2001 Frozen Whole Tilapia Thailand 
SAL2884 2/28/2002 Frozen Crab with Claws Sri Lanka 
SAL2885 10/18/2003 Coriander powder India 
SAL2886 4/16/2004 Fennel Seeds United Arab Emirates 
SAL2887 9/17/2004 Sand Goby Fish Vietnam 
SAL2888 12/28/2000 Frozen Shrimp India 
SAL2890 2/4/2004 Kheer mix Pakistan 
SAL2891 3/16/2004 Coriander powder India 
SAL2892 5/13/2005 Irrigation water USA 
SAL2893 1/13/2006 Frozen Fish India 
SAL2894 3/11/1997 Raw shrimp Vietnam 
SAL2895 2/16/2007 RED CHILI POWDER Pakistan 
SAL2896 12/5/2000 Crushed Chilies India 
SAL2897 4/21/2001 Sesame Seed India 
SAL2898 9/7/2004 Chili Powder Thailand 
SAL2900 3/9/2006 Coriander Mexico 
SAL2902 8/17/2007 Coconut India 
SAL2903 11/15/2001 Hilsa Fish Thailand 
SAL2904 12/4/2001 Frozen Rock Lobster Tails United Arab Emirates 
SAL2905 7/31/2002 Turmeric Powder India 




ID Date of 
Isolation 
Source Country 
SAL2907 2000-10-017 Shrimp India 
SAL2908 2/21/2006 Ground red pepper USA 
SAL2909 10/16/2007 Punjabi chole (king spice) India 
SAL2910 11/16/2006 Shrimp shell on Sri Lanka 
SAL2911 6/26/2007 Organic black pepper India 
SAL2912 11/17/2001 Cayenne Pepper India 
SAL2913 6/25/1996 scallops Indonesia 
SAL2914 7/8/1997 pabda fish Bangladesh 
SAL2915 10/11/1997 Frozen Rohu fish India 
SAL2916 3/26/1998 shrimp India 
SAL2917 11/7/1998 Cumin powder India 
SAL2918 3/13/2001 Coriander Bangladesh 
SAL2919 9/16/1999 Coriander powder India 
SAL2920 8/16/2002 Lobster Tails Taiwan 
SAL2921 2/7/2003 Frozen Baila Bangladesh 
SAL2922 5/31/2005 Chili Powder India 
SAL2923 11/12/2005 Fresh Water Fish (Bacha) Bangladesh 
SAL2924 4/5/2006 Fish stomach Vietnam 
SAL2925 9/8/2006 Chili powder India 
SAL3213 2/16/2008 Octopus India 
SAL3214 3/12/2008 Frozen shrimp Thailand 







Table IV. 3. Primers used for Salmonella enterica serotypes amplification and 
sequencing. 
Name Sequence Use 
CRISPR1 FW GATGTAGTGCGGATAATGCT Forward primer for both 
amplification and sequencing 
CRISPR1 REV1 GGTTTCTTTTCTTCCTGTTG Reverse primer for both 
amplification and sequencing* 
CRISPR1 REV2 GGTTTCTTTTCTTCCTGTTG Reverse primer for both 
amplification and sequencing* 
CRISPR2 FW ACCAGCCATTACTGGTACAC Forward primer for both 
amplification and sequencing 
CRISPR2 REV ATTGTTGCGATTATGTTGGT Reverse primer for both 
amplification and sequencing 
Bareilly C1 FWB AGTTCAACAAACACCACGACG Internal sequencing 
Bareilly C1 REVB CAGCTGAACAAACGTCAGGC Internal sequencing 
Braenderup C1 R1 ATATCGGAATTCAGCGCGGT Internal sequencing 
Montevideo A C1R1 CGTCCTGTGGAACCGGTTTA Internal sequencing 
Montevideo B C1F1 GGGATAAACCGGCTTCCCAA Internal sequencing 
Newport B C1R1 GGAACACGATGAGCAACACG Internal sequencing 
Typhimurium 
/Heildelberg C1R1 
CACAATCACTGCGGGGGTAT Internal sequencing 
Seftenberg C1F1 GGGATAAACCGGGCTGACAA Internal sequencing 
Seftenberg C1R1 AAAACC CCGACCAGTTTTGC Internal sequencing 
Tennessee C1F1 CAACCTTTCGCGCTAATGGTG Internal sequencing 
Tennessee C1R1 CAAGTGGCAGCAGAACACAC Internal sequencing 
Seftenberg C2F1 GTTTAAACGCCTTGCCGTGT Internal sequencing 
Seftenberg C2R1 GGGAACACGGTTTTTCGTCG Internal sequencing 
Mntevideo C2F1 TTGAGCGTTTCTCGGCTGAT Internal sequencing 
Newport B C2R1 TAGAGCACCGCGGTTTATCC Internal sequencing 
Typhimurium C2F1 TTCATAGTGCCCGTGTTCCC Internal sequencing 




Name Sequence Use 
Tennessee C2R2 TTAGCCGCTCGGTTTATCCC Internal sequencing 
NewportA C2R2 GGCGCGGGGAACACTATAAT Internal sequencing 
Muenster C2R1 GCGGGGAACACATACAGGAA Internal sequencing 




Table IV.4. General characteristics of CRISPR arrays from Salmonella enterica 
serotypes (n=224). 
Characteristic CRISPR1 CRISPR2 Combined 
Number arrays 221 221 22 
Number of non 
identical arrays 
97 92 111 
Spacers in array    
Range 1-62 1-32 2-88 
Average 17 14 31 
Mode 9 13 40 
    
Total spacers 3658 3086 6744 
Different spacers 744 565 1302* 
Unique spacers 
Spacers Length (bp) 
345 248 590 
Average 32 32 32 
Min 30 32 30 
Max 44 33 44 
Protospacers detected 13 7 20 




Chapter 5: Summary of findings, implications and future 
Studies 
 
Foodborne pathogens are an important source of infection for thousands of 
people in the word. WHO estimates one third of the world population suffers from 
foodborne diseases each year, and in the US it is estimated that about 50 million of 
cases occur annually. Early detection of contaminated food and water can help to 
prevent cases; therefore, the detection and evaluation of new molecular markers is 
fundamental to develop new and improved detection and identification methods. The 
objective of this research was to develop and analyze alternative techniques and 
markers for the detection of Salmonella enterica and Shigatoxin producing E. coli 
(STEC). 
In chapter II, a new suspension array assay was developed. The assay 
identifies and discriminates between the seven most important STEC from pure 
culture in a single reaction. Probes targeting genes wzx or wzy, serogroup specific 
genes, identified whether an isolate belonged to serotypes O26, O45, O103, O111, 
O121, O145, or O157. The assay also included probes targeting genes stx1 and stx2 
(Table II.3). Positive samples were clearly distinguished from negative samples 
(Table II.4), and a cut off ratio of 15 was set to differentiate between a positive and a 
negative isolate. 
The detection of STEC isolates from serogroups O26, O45, O103, O111, 
O121, O145, and O157 is important because they are considered adulterants when 
found in meat and meats products. The use of fast molecular techniques that detect 




of human disease due to seize of contaminated products; the use of suspension arrays 
seems a promising alternative for developing fast detection and identification 
techniques. This is the first time a suspension array assay identifies not only 
serogroups but also Shiga toxin genes, which allows to classify isolates as STEC. The 
method developed represents a reliable alternative for molecular serotyping of E. coli, 
and can be useful to better understand the epidemiology of STEC infections and 
enhance outbreak investigations. Further studies will aim to design a complementary 
second panel that includes the next top 20 O STEC serogroups, as well as optimizing 
the panel for the detection of STECs from foods. 
 
In chapter III, CRISPR arrays of 194 STEC strains were described and 
characterized, and a potential relationship between array length and virulence markers 
was explored. It was found that strains of a same serotyped clustered together, but 
strains of the same O serogroups did not necessarily formed blocks (Fig 1). Instead, 
some strains of different serogroup but the same H type clustered together and share 
most of their spacers. These findings suggest that H antigen genes would be more 
phylogenetic stable than O antigen, or that H antigen was acquired more ancestrally 
than O antigen in STEC. This has been recently suggested by other researchers and 
suggests a shift in the paradigm of STEC evolution. 
CRISPR function is to prevent the invasion of horizontal gene transfer 
elements, and many of virulence determinants were acquired in that way in E. coli. 
The hypothesis that there is an inverse correlation between the presence of CRISPR 




was not linked to virulence elements. However, array length was related to several 
virulence characteristics; strains of seropathotypes more likely to cause outbreak and 
severe disease had longer CRISPR that those of other seropathotypes. Strains with 
one type of Shigatoxin genes had longer arrays than those with two, and shorter 
arrays were a marker for the presence of some virulence genes. This relationship may 
suggest that CRISPR systems had interfered with the acquisition of virulence traits in 
STEC. Further studies, using additional and genetically diverse strains, would provide 
a better understanding of the CRISPR-Cas system in STEC, and E. coli as a group. If 
the relationship between CRISPR array length and presence of virulence markers is 
true, array length could be used to predict high risk STEC strains and could be a 
useful tool for the control of STEC infections. 
 
In chapter IV, CRISPR arrays of 221 Salmonella enterica subspecies enterica 
(S. enterica) were described, and the CRISPR-cas system of the emerging serotype S. 
enterica serotype Bareilly (S. Bareilly) was analyzed. Similarly to STEC strains, 
CRISPR arrays of Salmonella enterica correlate well with serotypes, and could be 
used to develop molecular serotyping assays. However, some serotypes displayed 
more than one type of array. It has been suggested that CRISPR arrays reflect 
phylogeny of Salmonella enterica. One of the serotypes presented different patters 
was Salmonella Newport, and it has been documented that convergent evolution 
created this serotype from different Salmonella lineages. 
CRISPR-cas analysis of S. Bareilly revealed that there are two patterns in 




spacer pattern. The variation in CRISPR arrays was also reflected in leader sequences 
and cas genes. Interestingly, variations corresponded with those showed by 
housekeeping genes, which reflect phylogenetic relationships (29). This suggests the 
presence of two lineages of Salmonella Bareilly, a finding that has not been 
previously described in literature. 
CRISPR arrays seem suitable for developing molecular serotyping methods 
for S. enterica, but it is necessary to include a higher number of strains from different 
geographical locations, food vehicle and hosts, thus creating a more comprehensive 
database of CRISPR arrays and spacers. Also, the low rate of variation of CRISPR 
arrays in different Salmonella serotypes, especially in a large sample of Salmonella 
Bareilly with different PFGE pattern, geographical origin and food vehicle, confirms 
that CRISPR arrays are not suitable for Salmonella subtyping unless other genetic 
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